propranolol has been researched along with Body Weight in 332 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol has been widely used in the treatment of infantile hemangiomas since 2008." | 9.22 | Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas. ( Chang, L; Chen, H; Hu, L; Huang, H; Jin, Y; Li, W; Lin, X; Ma, G; Qiu, Y; Xu, X; Zhou, B, 2016) |
| "In a double-blind controlled trial 22 patients with mild or moderate essential hypertension were treated with nicardipine 30 mg t." | 9.06 | Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. ( Karppinen, K; Naukkarinen, VA; Sarna, S, 1987) |
| "We report the first comparative study on enalapril maleate, a new angiotensin converting enzyme inhibitor, in patients with uncomplicated mild to moderate essential hypertension." | 9.05 | Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). ( , 1984) |
| "Twenty-four patients with moderate to severe hypertension were treated for four weeks with captopril, an oral inhibitor of angiotensin-converting enzyme." | 9.05 | Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. ( Banks, RA; Bayliss, J; Jones, JC; MacGregor, GA; Markandu, ND; Roulston, JE, 1982) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 9.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 9.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 9.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "1 A double-blind cross over trial between clonidine, propranolol and a placebo in patients with moderate hypertension has been performed." | 9.04 | A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. ( Raftery, EB; Wilkinson, PR, 1977) |
| "15 patients who had benign, uncomplicated essential hypertension, were treated with chlorthiazide (500 mg twice a day) with or without propranolol (10--20 mg 4 times a day), and the effect of the treatment on plasma renin activity (PRA), urinary aldosterone excretion, total body potassium (TBK) and plasma sodium and potassium was evaluated." | 9.04 | The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension. ( Carroll, HJ; Oh, MS, 1978) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 9.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "The efficacy of lauromacrogol injection therapy and intralesional triamcinolone for infantile hemangiomas (IH) has been well documented recently, but with an increase in serious or rare adverse reactions." | 7.91 | Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas. ( Bi, J; Chai, Y; Huo, R; Li, X; Li, Z; Lv, R; Song, J; Xu, G; Zhou, Z, 2019) |
| "Despite the increasing popularity of propranolol for treatment of infantile hemangioma (IH), there is need for further evidence of efficacy and safety." | 7.83 | Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas. ( Gehris, R; Geisler, S; Grunwaldt, LJ; MacIsaac, ZM; Mehta, D; Nayar, HS, 2016) |
| "The effect of the hypothyroidism induced by thiamazole on toxic interactions between propranolol and disopyramide were studied in chick embryos." | 7.73 | Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos. ( Kanke, M; Yoshiyama, Y, 2005) |
| "To examine the pharmacokinetic profile of propranolol in cats before and during experimentally induced hyperthyroidism." | 7.69 | Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states. ( Calvert, C; Ferguson, D; Jacobs, G; Sams, R; Whittem, T, 1997) |
| "Plasma atrial natriuretic peptide (ANP), plasma renin activity (PRA) and aldosterone were consecutively measured during methimazole treatment in patients with hyperthyroidism due to Graves' disease." | 7.67 | Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease. ( Aizawa, T; Ishihara, M; Iwasaki, T; Sato, A; Shigematsu, S; Shinoda, T; Takemura, Y; Yamada, T, 1989) |
| " Experimental hyperthyroidism was induced by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g body weight) for 3 days." | 7.67 | Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G, 1987) |
| "Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration." | 7.67 | Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986) |
| "High doses of propranolol administered to rats during pregnancy and lactation cause inhibition of growth of the neonatal rats." | 7.67 | Effects of propranolol during pregnancy and development of rats. II. Adverse effects on development. ( Atsmon, A; Epstein, O; Rosen, M; Schoenfeld, N, 1985) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 7.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| " Also, the influence of propranolol withdrawal on vulnerability to aconitine-induced arrhythmias in vivo was evaluated in anesthetized rats." | 7.66 | Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats. ( Hedberg, A; Isaksson, O; Lundgren, B, 1980) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 7.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 7.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| "The blood pressure response to propranolol treatment was analyzed retrospectively in 187 patients with benign essential hypertension." | 7.65 | Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. ( Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Weber, MA, 1976) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 6.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| " Also during treatment, fewer patients receiving hydrochlorothiazide required termination as compared with those receiving propranolol; comparative dosage requirements were lower; additional titration during long-term treatment was required less often, and BP remained lower after withdrawal of the active drugs." | 6.65 | Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. ( , 1982) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 6.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 5.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| "Propranolol has been widely used in the treatment of infantile hemangiomas since 2008." | 5.22 | Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas. ( Chang, L; Chen, H; Hu, L; Huang, H; Jin, Y; Li, W; Lin, X; Ma, G; Qiu, Y; Xu, X; Zhou, B, 2016) |
| "After 4 days of drug treatment with comparable doses of propranolol (40 and 80 mg), metoprolol (50 and 100 mg), or placebo, mood (POMS) and anxiety states (STAI) were assessed in healthy volunteers, before and after 1 h of treadmill walking exercise at 50% maximum oxygen uptake." | 5.08 | Acute effects of beta blockade and exercise on mood and anxiety. ( Eagles, C; Ferner, R; Head, A; Kendall, MJ, 1996) |
| "Seventeen patients with hypertension and osteoarthritis participated in a single-blind crossover study comparing the effects of sulindac 200 mg twice daily, naproxen 500 mg twice daily, and placebo on blood pressure." | 5.06 | Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients. ( Day, R; Goodfriend, TL; Hiatt, JG; Kochar, M; Schuna, AA; Vejraska, BD, 1989) |
| "In a double-blind controlled trial 22 patients with mild or moderate essential hypertension were treated with nicardipine 30 mg t." | 5.06 | Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. ( Karppinen, K; Naukkarinen, VA; Sarna, S, 1987) |
| "We report the first comparative study on enalapril maleate, a new angiotensin converting enzyme inhibitor, in patients with uncomplicated mild to moderate essential hypertension." | 5.05 | Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). ( , 1984) |
| "Twenty-four patients with moderate to severe hypertension were treated for four weeks with captopril, an oral inhibitor of angiotensin-converting enzyme." | 5.05 | Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. ( Banks, RA; Bayliss, J; Jones, JC; MacGregor, GA; Markandu, ND; Roulston, JE, 1982) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 5.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "The effects of 100 mg indomethacin daily for three weeks on blood pressure and urinary excretion of prostaglandin F2 alpha were studied in a double-blind, placebo-controlled comparison of two groups of patients with essential hypertension, eight receiving propranolol and seven thiazide diuretics." | 5.05 | Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. ( Abbott, EC; Dollery, CT; Hensby, CN; Watkins, J; Webster, J, 1980) |
| "Because captopril alone does not control blood pressure in all patients with essential hypertension, studies were performed to assess the effect of sodium intake and of captopril combined with hydrochlorothiazide, propranolol, and nifedipine." | 5.05 | Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. ( MacGregor, GA; Markandu, ND; Sagnella, GA; Smith, SJ, 1985) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 5.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 5.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| " No significant differences were found for blood pressure, heart rate, body weight or serum uric acid." | 5.04 | Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study. ( Bengtsson, C, 1976) |
| "Studies in 55 patients with benign essential hypertension showed that the beta-blockers bufuralol (22 patients) and propranolol (33 patients) at a dose ratio of 1:4, possess comparable antihypertensive efficacy despite different properties regarding intrinsic sympathomimetic activity." | 5.04 | [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)]. ( Beretta-Piccoli, C; de Châtel, RD; Hirsch, D; Reubi, FC; Weidmann, P; Ziegler, W, 1976) |
| "1 A double-blind cross over trial between clonidine, propranolol and a placebo in patients with moderate hypertension has been performed." | 5.04 | A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. ( Raftery, EB; Wilkinson, PR, 1977) |
| "15 patients who had benign, uncomplicated essential hypertension, were treated with chlorthiazide (500 mg twice a day) with or without propranolol (10--20 mg 4 times a day), and the effect of the treatment on plasma renin activity (PRA), urinary aldosterone excretion, total body potassium (TBK) and plasma sodium and potassium was evaluated." | 5.04 | The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension. ( Carroll, HJ; Oh, MS, 1978) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 5.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| " Out of 439 patients, 292 were enrolled to examine the effect of propranolol on 2-year-olds' height and body weight (BW), by comparison with reference range and among groups." | 3.91 | Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two. ( Huo, R; Li, H; Li, X; Yang, K, 2019) |
| "The efficacy of lauromacrogol injection therapy and intralesional triamcinolone for infantile hemangiomas (IH) has been well documented recently, but with an increase in serious or rare adverse reactions." | 3.91 | Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas. ( Bi, J; Chai, Y; Huo, R; Li, X; Li, Z; Lv, R; Song, J; Xu, G; Zhou, Z, 2019) |
| "Despite the increasing popularity of propranolol for treatment of infantile hemangioma (IH), there is need for further evidence of efficacy and safety." | 3.83 | Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas. ( Gehris, R; Geisler, S; Grunwaldt, LJ; MacIsaac, ZM; Mehta, D; Nayar, HS, 2016) |
| " A reduction of body weight was seen and urinary glucose excretion, increase in body temperature, reduction in maximal plasma glucose and insulin levels in the oral glucose tolerance test, and stimulation of glucose transport into skeletal muscle and adipose tissue, were completely attenuated by the non-specific β-AR antagonist propranolol." | 3.78 | Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). ( Russell, ST; Tisdale, MJ, 2012) |
| " Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia." | 3.75 | Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009) |
| " This bradycardia was blocked by atropine." | 3.74 | Parasympathetic response to acute stress is attenuated in young Zucker obese rats. ( Brown, DR; El-Wazir, YM; Li, SG; Randall, DC; Silcox, DL; Smith, R, 2008) |
| "Ingestion of propranolol at 10 and 15 mg kg(-1) body weight for 35 days by adult male mice was investigated for its effects on fertility." | 3.74 | Adverse effects of propranolol on reproductive function in adult male mice. ( Bataineh, HN; Daradka, HM; Nusier, MK, 2007) |
| "The effect of the hypothyroidism induced by thiamazole on toxic interactions between propranolol and disopyramide were studied in chick embryos." | 3.73 | Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos. ( Kanke, M; Yoshiyama, Y, 2005) |
| "A chronic administration of isoproterenol hydrochloride (60 mg/kg body weight; 30 days) alters the collagen metabolism in denervated gastrocnemius muscle of mice." | 3.73 | Remodeling of extracellular matrix protein, collagen by beta-adrenoceptor stimulation and denervation in mouse gastrocnemius muscle. ( Kumar, R; Sharma, S, 2006) |
| " Hyperthyroidism was produced by three injections of 100 microg T3/100 g body weight on alternate days with or without concomitant treatment with either captopril (an angiotensin-converting enzyme [ACE] inhibitor), propranolol (a beta-blocker) or clenbuterol (a beta2-agonist)." | 3.72 | Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle. ( Ismail-Beigi, F; Queiroz, MS; Shao, Y, 2004) |
| "The effects of propranolol and atenolol were investigated on arterial hypertension, cardiomyocyte hypertrophy, and ventricular ischaemic lesions induced by an 8-week treatment with the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME; 20 mg/rat per day) in Wistar rats." | 3.71 | Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. ( Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR, 2002) |
| " This resulted in hyperinsulinaemia and moderate hypoglycaemia, the latter probably counteracted by overeating and increased glucagon secretion, as indicated by increased body weight and lower liver glycogen contents, respectively." | 3.69 | The effects of long-term hyperinsulinaemia on insulin sensitivity in rats. ( Björntorp, P; Holmäng, A; Jennische, E, 1995) |
| "To examine the pharmacokinetic profile of propranolol in cats before and during experimentally induced hyperthyroidism." | 3.69 | Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states. ( Calvert, C; Ferguson, D; Jacobs, G; Sams, R; Whittem, T, 1997) |
| "Increased motor activity and poor performance in the active avoidance test were observed in the offspring of rats treated with dl-propranolol or sotalol during pregnancy, but not with atenolol and d-propranolol." | 3.68 | Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. ( Gitter, S; Gordon, I; Rehavi, M; Speiser, Z, 1991) |
| " Furthermore, insulin but not myoinositol treatment normalized blood glucose and insulin levels, maintained normal prostate and body weight-gain, and prevented the decrease in the density, i." | 3.68 | Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol. ( Gousse, A; Latifpour, J; Weiss, RM; Yoshida, M, 1991) |
| "In patients with mild hypertension, flurbiprofen in a dose of 100 mg daily for 7 days attenuated the hypotensive effect of a single dose of propranolol 80 mg but not of atenolol 100 mg." | 3.67 | Flurbiprofen interaction with single doses of atenolol and propranolol. ( Hawksworth, GM; McLean, I; Petrie, JC; Webster, J, 1984) |
| "Plasma atrial natriuretic peptide (ANP), plasma renin activity (PRA) and aldosterone were consecutively measured during methimazole treatment in patients with hyperthyroidism due to Graves' disease." | 3.67 | Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease. ( Aizawa, T; Ishihara, M; Iwasaki, T; Sato, A; Shigematsu, S; Shinoda, T; Takemura, Y; Yamada, T, 1989) |
| " Experimental hyperthyroidism was induced by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g body weight) for 3 days." | 3.67 | Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G, 1987) |
| "The effects of propranolol (10 mg/kg) on systolic blood pressure (SBP), resting and exercising heart rates (HR), and body weight (BW) were examined in 11-week swim-trained spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats." | 3.67 | Attenuation by propranolol of exercise training effects in spontaneously hypertensive rats. ( Allevard, AM; Augoyard, G; Desplanches, D; Favier, R; Gauquelin, G; Ghaemmaghami, F; Gharib, C, 1987) |
| "Heavy male Sprague-Dawley rats die of ventricular fibrillation within 2 to 3 h after isoproterenol administration." | 3.67 | Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death. ( Balazs, T; Ehrreich, SJ; el-Hage, AN; Johnson, GL, 1986) |
| "Experimental hyperthyroidism was induced in rats by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g bw) for 3 days (short-term experiment) or by subcutaneous injections of T3 (30 micrograms/100 g bw) on alternate days during 6 weeks (long-term experiment)." | 3.67 | Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R, 1986) |
| "High doses of propranolol administered to rats during pregnancy and lactation cause inhibition of growth of the neonatal rats." | 3.67 | Effects of propranolol during pregnancy and development of rats. II. Adverse effects on development. ( Atsmon, A; Epstein, O; Rosen, M; Schoenfeld, N, 1985) |
| "The effect of propranolol (Pr) on body weight was studied in 144 Wistar rats of both sexes from weaning to 17 weeks of age." | 3.66 | Effect of beta-adrenergic blockade on physiologic growth in the Wistar rat. ( Boudoulas, H; Donta, I; Karayannacos, PE; Kostakis, A; Scalkeas, GR; Sechas, M; Varonos, D, 1982) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 3.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| " Also, the influence of propranolol withdrawal on vulnerability to aconitine-induced arrhythmias in vivo was evaluated in anesthetized rats." | 3.66 | Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats. ( Hedberg, A; Isaksson, O; Lundgren, B, 1980) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 3.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "The effects of propranolol (100 mg/kg), atenolol (200 mg/kg) and acebutolol (1000 mg/kg) administered daily by gavage to spontaneously hypertensive rats (SHRs) from their 6th to 20th weeks of age were investigated on genetic hypertension development (GHD) and at regular intervals on heart rate (HR), cardiac output (CO), stroke volume (SV), peripheral resistence (PR), plasma renin concentration (PRC) and heart weight/body weight ratio (HW/BW)." | 3.66 | beta-Adrenoreceptor blockage and genetic hypertension development in rats. ( Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N, 1980) |
| "Propranolol alone was given to sixteen hyperthyroid, and concomitantly with thyroxine therapy to ten hypothyroid patients." | 3.66 | Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease. ( Crooks, J; Feely, J; Isles, TE; Ratcliffe, WA, 1979) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 3.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| "The blood pressure response to propranolol treatment was analyzed retrospectively in 187 patients with benign essential hypertension." | 3.65 | Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. ( Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Weber, MA, 1976) |
| "In 79 patients with essential hypertension, treatment with propranolol hydrochloride and chlorthalidone together produced significantly greater falls in both systolic and diastolic blood pressures than were obtained with either drug alone." | 3.65 | Renin reactivity as a determinant of responsiveness to antihypertensive treatment. ( Case, DB; Drayer, JI; Laragh, JH; Lopez-Ovejero, JA; Weber, MA, 1977) |
| " Propranolol lowered the heart rate, but did not alter the following changes induced by T4: increment in heart rate, increase in heart or kidney weight, increase in urinary hydroxyproline, decrease in body weight gain or increase in serum T4." | 3.65 | Effects of propranolol on changes in heart rate, heart weight, kidney weight, urinary hydroxyproline and weight gain induced by large doses of thyroxine in the rat. ( Goulding, A; McChesney, R; Stewart, RD, 1976) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 2.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| "Pinacidil is a direct vasodilator with good absorption, a half-life of 2 to 4 hours, and side effects similar to those of other vasodilators." | 2.66 | A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension. ( Byyny, RL; LoVerde, ME; Mitchell, WD; Nies, AS, 1987) |
| "Propranolol treatment was associated with a significant rise in body weight after 9 months and significant rises in skinfold thickness and body fat after 12 months." | 2.65 | Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease. ( Bouchier, IA; Hayes, PC; Stewart, WW, 1984) |
| " Also during treatment, fewer patients receiving hydrochlorothiazide required termination as compared with those receiving propranolol; comparative dosage requirements were lower; additional titration during long-term treatment was required less often, and BP remained lower after withdrawal of the active drugs." | 2.65 | Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. ( , 1982) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 2.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| "These results suggest that Bartter's syndrome results from beta adrenergic and prostaglandin-mediated proximal tubular rejection of sodium leading to increased distal sodium-potassium exchange." | 2.35 | Role of prostaglandins in the pathogenesis of Bartter's syndrome. ( Fichman, MP; Golub, M; Rude, R; Speckart, P; Telfer, N; Zia, P, 1976) |
| "Brain edema was determined by hemispheric wet-to-dry ratios." | 1.72 | Beta blockade in TBI: Dose-dependent reductions in BBB leukocyte mobilization and permeability in vivo. ( Ahmed, S; Culkin, MC; ElSaadani, M; Georges, A; Jacovides, CL; Kaplan, LJ; Kumar, MA; Lopez, AJ; Pascual, JL; Smith, DH, 2022) |
| "The propranolol group was treated with propranolol ointment and the control group was treated with propranolol matrix cream to cover the wound surface." | 1.51 | Propranolol regulates ERK1/2 signaling pathway and promotes chronic wound healing in diabetic rats. ( Chang, F; Chang, X; Li, S; Xue, XD, 2019) |
| "Periodontal disease is characterised by alveolar bone loss." | 1.36 | Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model. ( Hamada, N; Kim, Y; Okada, Y; Ozono, S; Sasaguri, K; Sato, S; Takahashi, Y, 2010) |
| "Obesity is associated with endothelial dysfunction and inflammation." | 1.35 | Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism. ( Fagan, K; Frye, M; McMurtry, I; Orton, EC, 2009) |
| "Osteoporosis is one of the major health problems in our modern world." | 1.33 | Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. ( Denhardt, DT; Ezura, Y; Karsenty, G; Kondo, H; Nakashima, K; Nifuji, A; Noda, M; Rittling, SR; Takeda, S, 2005) |
| "Depression is a multifaceted psychological disorder that involves changes in behavior, neuroendocrine function, and physiological responses." | 1.32 | Behavioral and cardiovascular changes in the chronic mild stress model of depression. ( Beltz, TG; Grippo, AJ; Johnson, AK, 2003) |
| "Morphine withdrawal was precipitated by administration of naloxone (5 mg/kg subcutaneously) on day 8." | 1.32 | Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors. ( Aviles, M; González-Cuello, A; Laorden, ML; Milanés, MV, 2004) |
| "Isoproterenol-treatment significantly increased acid phosphatase concentration in the ventral prostate of intact rats, whereas propranolol prevented a glandular zinc loss induced by dexamethasone administration." | 1.31 | beta-Adrenergic receptor manipulation and acid phosphatase and zinc levels in the ventral prostate of the adult rat. ( Hristić, M; Lalić, N; Pesić, V; Plećas, B; Solarović, T, 2000) |
| "Isoproterenol pretreatment caused cardiac hypertrophy (29%) as shown by a significant increase in the ratio of ventricular dry weight to body weight." | 1.31 | Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts. ( Duarte, GP; Lahlou, S; Monteiro-Filho, WO; Silva, CO, 2001) |
| "Portal hypertension was induced by partial portal vein ligation (PVL)." | 1.30 | Increased angiogenesis in portal hypertensive rats: role of nitric oxide. ( Battegay, E; Sieber, CC; Stumm, M; Sumanovski, LT; van der Kooij, M, 1999) |
| "Propranolol is a lipophilic non-selective beta-blocker mainly eliminated via the liver; atenolol is a hydrophilic beta 1-selective blocking agent, mainly eliminated via the kidney." | 1.29 | Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats. ( Ameri, L; Arias, E; Girotti, P; Mazzoleni, G; Presta, M; Radaelli, G; Ragnotti, G; Zavanella, T, 1994) |
| "Predisposition to obesity has been suggested to be related to a low energy expenditure (EE)." | 1.29 | [Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight]. ( Astrup, AV; Buemann, B, 1993) |
| "Body wasting (cachexia) is a common feature of cancer and a major cause of morbidity and mortality." | 1.29 | Mechanisms of cachexia induced by T-cell leukemia in the rat. ( Cooper, AL; Morris, ID; Roe, S; Rothwell, NJ, 1996) |
| "Propranolol was used to inhibit elevated adrenergic activity." | 1.29 | Rapid formation of capillary endothelial cells in rat skeletal muscle after exposure to insulin. ( Björntorp, P; Holmäng, A; Jennische, E, 1996) |
| "Propranolol treatment from day 11-20 only marginally increased MHPG on day 20 and induced no lasting differences." | 1.28 | Chronic propranolol treatment in developing rats: acute and lasting effects on monoamines and beta-adrenergic receptors in the rat brain. ( Boer, GJ; Erdtsieck-Ernste, EB; Feenstra, MG; van Galen, H, 1991) |
| "The pindolol-treated and propranolol-treated rats gained weight during the cold-acclimatization period." | 1.28 | Influence of two beta-adrenoceptor antagonists, propranolol and pindolol, on cold adaptation in the rat. ( Huttunen, P; Kortelainen, ML; Lapinlampi, T, 1990) |
| "Treatment with prazosin, an alpha 1-noradrenergic receptor antagonist, reduced Na+-K+-ATPase in either control or cafeteria diet-fed rats but did not alter the effect of cafeteria diet feeding." | 1.27 | Caloric intake and Na+-K+-ATPase: differential regulation by alpha 1- and beta-noradrenergic receptors. ( Swann, AC, 1984) |
| " The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart." | 1.27 | Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984) |
| "Arotinolol (S-596, ARL) is a beta-adrenoceptor blocking drug with weak alpha-adrenoceptor blocking activity, and may be classified into the fourth generation." | 1.27 | Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats. ( Kawashima, K; Kishi, K; Saito, K; Sokabe, H, 1985) |
| "Propranolol (PPL) was used as the reference drug." | 1.27 | Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats. ( Ishii, Y; Kawase, S; Kawashima, K; Kishi, K; Kubota, N; Sokabe, H, 1985) |
| "Hyperthyroidism is frequently associated with myopathy." | 1.27 | The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Oldfors, A, 1986) |
| "Atropine treatment decreased, and phentolamine administration elicited a greater absolute and percent change increase in insulin levels of decerebrate rats." | 1.27 | Pre- and postabsorptive insulin secretion in chronic decerebrate rats. ( Berridge, KC; Flynn, FW; Grill, HJ, 1986) |
| " After intravenous administration there was no difference in plasma clearance but the volume of distribution was greater (V = 339 l vs 198 l) and the half-life was longer (t1/2 = 5." | 1.27 | A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. ( Bowman, SL; Clements, JA; Hudson, SA; Munro, JF; Simpson, G, 1986) |
| "Clonidine was given in doses of 0." | 1.26 | Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients. ( Mitchell, HC; Pettinger, WA, 1981) |
| "Quipazine, in mice pretreated with pargyline, induced head twitches which were inhibited by methysergide but not by D,L-propranolol." | 1.26 | Evidence for the role of noradrenaline in some effects of quipazine. ( Francès, H; Lecrubier, Y; Puech, AJ; Simon, P, 1980) |
| "1 L/min) propranolol although the half-life of propranolol did not change significantly." | 1.26 | Increased clearance of propranolol in thyrotoxicosis. ( Crooks, J; Feely, J; Stevenson, IH, 1981) |
| " In a group of 40 patients, including 10 severely thyrotoxic patients, who had the dosage of propranolol titrated objectively preoperatively to bring about a greater than 25% reduction in exercise heart rate at the end of a dosage interval, no case of thyroid storm was encountered." | 1.26 | Propranolol dosage in thyrotoxicosis. ( Crooks, J; Feely, J; Forrest, A; Gunn, A; Hamilton, W; Stevenson, I, 1980) |
| "Hyperthyroidism has been induced to rabbits by a daily subcutaneous injection of D-L thyroxine (0." | 1.26 | Myosin synthesis and enzymatic properties during thyroxine intoxication in rabbits. ( Delcayre, C; Swynghedauw, B, 1979) |
| " The bioavailability of tablets and a solution of propranolol was compared with a crossover design by obtaining plasma samples at the end of the dosage interval during chronic oral administration of various doses." | 1.26 | Disposition of propoxyphene and propranolol in children. ( Atwood, GF; Shand, DG; Wilson, JT, 1976) |
| " Propranolol in a dosage of 0." | 1.25 | The effect of -adrenoceptor blockade on human sweating. ( Allen, JA; Jenkinson, DJ; Roddie, IC, 1973) |
| "3 Isoprenaline dose-response curves were shifted to the right in the cats administered oxyfedrine as well as in those administered propranolol." | 1.25 | The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol. ( Parratt, JR, 1974) |
| " All three catecholamines increased the rate of weight loss but isoprenaline was effective in a much smaller dosage than either adrenaline or noradrenaline." | 1.25 | The role of circulating catecholamines in sweat production in man. ( Allen, JA; Roddie, IC, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 221 (66.57) | 18.7374 |
| 1990's | 54 (16.27) | 18.2507 |
| 2000's | 34 (10.24) | 29.6817 |
| 2010's | 21 (6.33) | 24.3611 |
| 2020's | 2 (0.60) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Y | 1 |
| Hu, M | 1 |
| Yang, L | 1 |
| Li, X | 3 |
| Bian, J | 1 |
| Jiang, F | 1 |
| Sun, H | 1 |
| You, Q | 1 |
| Zhang, X | 1 |
| Lopez, AJ | 1 |
| ElSaadani, M | 1 |
| Jacovides, CL | 1 |
| Georges, A | 1 |
| Culkin, MC | 1 |
| Ahmed, S | 1 |
| Kumar, MA | 1 |
| Kaplan, LJ | 1 |
| Smith, DH | 1 |
| Pascual, JL | 1 |
| Yang, K | 1 |
| Li, H | 2 |
| Huo, R | 2 |
| Gemici, A | 1 |
| Sinen, O | 1 |
| Bülbül, M | 1 |
| Lezón, CE | 1 |
| Pintos, PM | 1 |
| Bozzini, C | 1 |
| Romero, AA | 1 |
| Casavalle, P | 1 |
| Friedman, SM | 1 |
| Boyer, PM | 1 |
| Baek, K | 2 |
| Kang, J | 1 |
| Lee, J | 1 |
| Kim, M | 1 |
| Baek, JH | 2 |
| Del Frari, L | 1 |
| Léauté-Labrèze, C | 1 |
| Guibaud, L | 1 |
| Barbarot, S | 1 |
| Lacour, JP | 1 |
| Chaumont, C | 1 |
| Delarue, A | 1 |
| Voisard, JJ | 1 |
| Brunner, V | 1 |
| Chang, X | 1 |
| Li, S | 1 |
| Xue, XD | 1 |
| Chang, F | 1 |
| Chai, Y | 1 |
| Zhou, Z | 1 |
| Song, J | 1 |
| Lv, R | 1 |
| Xu, G | 1 |
| Bi, J | 1 |
| Li, Z | 1 |
| Marks, C | 1 |
| Eme, J | 1 |
| Elsey, RM | 1 |
| Crossley, DA | 1 |
| Hwang, HR | 1 |
| Park, HJ | 1 |
| Kwon, A | 1 |
| Qadir, AS | 1 |
| Shimojo, GL | 1 |
| Palma, RK | 1 |
| Brito, JO | 1 |
| Sanches, IC | 1 |
| Irigoyen, MC | 2 |
| De Angelis, K | 2 |
| MacIsaac, ZM | 1 |
| Nayar, HS | 1 |
| Gehris, R | 1 |
| Mehta, D | 1 |
| Geisler, S | 1 |
| Grunwaldt, LJ | 1 |
| Hu, L | 1 |
| Zhou, B | 1 |
| Huang, H | 1 |
| Chang, L | 1 |
| Qiu, Y | 1 |
| Ma, G | 1 |
| Chen, H | 1 |
| Jin, Y | 1 |
| Xu, X | 1 |
| Lin, X | 1 |
| Li, W | 1 |
| Moyakine, AV | 1 |
| Kerstjens, JM | 1 |
| Spillekom-van Koulil, S | 1 |
| van der Vleuten, CJ | 1 |
| Kawao, N | 1 |
| Morita, H | 1 |
| Obata, K | 1 |
| Tamura, Y | 1 |
| Okumoto, K | 1 |
| Kaji, H | 1 |
| El-Wazir, YM | 1 |
| Li, SG | 1 |
| Smith, R | 1 |
| Silcox, DL | 1 |
| Brown, DR | 1 |
| Randall, DC | 1 |
| Nusier, MK | 1 |
| Bataineh, HN | 1 |
| Daradka, HM | 1 |
| Sutherland, LN | 1 |
| Bomhof, MR | 1 |
| Capozzi, LC | 1 |
| Basaraba, SA | 1 |
| Wright, DC | 1 |
| Shen, KP | 1 |
| Lin, HL | 1 |
| Hsieh, SL | 1 |
| Kwan, AL | 1 |
| Chen, IJ | 1 |
| Wu, BN | 1 |
| Mori, S | 1 |
| Satou, M | 1 |
| Kanazawa, S | 1 |
| Yoshizuka, N | 1 |
| Hase, T | 1 |
| Tokimitsu, I | 1 |
| Takema, Y | 1 |
| Nishizawa, Y | 1 |
| Yada, T | 1 |
| Hattori, A | 1 |
| Mawatari, K | 1 |
| Tsuzuki, S | 1 |
| Yoshioka, E | 1 |
| Toda, S | 1 |
| Yoshida, M | 3 |
| Yasui, S | 1 |
| Furukawa, H | 1 |
| Morishima, M | 1 |
| Ono, K | 1 |
| Ohnishi, T | 1 |
| Nakano, M | 1 |
| Harada, N | 1 |
| Takahashi, A | 1 |
| Nakaya, Y | 1 |
| Thom, NJ | 1 |
| Holmes, PV | 1 |
| Dishman, RK | 1 |
| Owen, SF | 1 |
| Huggett, DB | 1 |
| Hutchinson, TH | 1 |
| Hetheridge, MJ | 1 |
| Kinter, LB | 1 |
| Ericson, JF | 1 |
| Sumpter, JP | 1 |
| Naghshin, J | 1 |
| McGaffin, KR | 1 |
| Witham, WG | 1 |
| Mathier, MA | 1 |
| Romano, LC | 1 |
| Smith, SH | 1 |
| Janczewski, AM | 1 |
| Kirk, JA | 1 |
| Shroff, SG | 1 |
| O'Donnell, CP | 1 |
| Vieira, VJ | 1 |
| Valentine, RJ | 1 |
| Frye, M | 1 |
| McMurtry, I | 1 |
| Orton, EC | 1 |
| Fagan, K | 1 |
| Plaisance, EP | 1 |
| Henagan, TM | 1 |
| Echlin, H | 1 |
| Boudreau, A | 1 |
| Hill, KL | 1 |
| Lenard, NR | 1 |
| Hasek, BE | 1 |
| Orentreich, N | 1 |
| Gettys, TW | 1 |
| Okada, Y | 1 |
| Hamada, N | 1 |
| Kim, Y | 1 |
| Takahashi, Y | 1 |
| Sasaguri, K | 1 |
| Ozono, S | 1 |
| Sato, S | 1 |
| Pontes, DA | 1 |
| Fernandes, GS | 1 |
| Piffer, RC | 1 |
| Gerardin, DC | 1 |
| Pereira, OC | 1 |
| Kempinas, WG | 1 |
| Russell, ST | 2 |
| Tisdale, MJ | 2 |
| Reboredo, M | 1 |
| Chang, HC | 1 |
| Barbero, R | 1 |
| Rodríguez-Ortigosa, CM | 1 |
| Pérez-Vizcaíno, F | 1 |
| Morán, A | 1 |
| García, M | 1 |
| Banales, JM | 1 |
| Carreño, N | 1 |
| Alegre, F | 1 |
| Herrero, I | 1 |
| Quiroga, J | 1 |
| Prieto, J | 1 |
| Sangro, B | 1 |
| Mircoli, L | 1 |
| Fedele, L | 1 |
| Benetti, M | 1 |
| Bolla, GB | 1 |
| Radaelli, A | 1 |
| Perlini, S | 1 |
| Ferrari, AU | 1 |
| Grippo, AJ | 1 |
| Beltz, TG | 1 |
| Johnson, AK | 1 |
| Mann, KM | 1 |
| Sleigh, MJ | 1 |
| Zaninovich, AA | 1 |
| Rebagliati, I | 1 |
| Raices, M | 1 |
| Ricci, C | 1 |
| Hagmuller, K | 1 |
| Braga, MF | 1 |
| Aroniadou-Anderjaska, V | 1 |
| Manion, ST | 1 |
| Hough, CJ | 1 |
| Anikina, TA | 1 |
| Bilalova, GA | 1 |
| Sitdikov, FG | 1 |
| Yuan, Z | 1 |
| Shioji, K | 1 |
| Kihara, Y | 1 |
| Takenaka, H | 1 |
| Onozawa, Y | 1 |
| Kishimoto, C | 1 |
| Wichi, RB | 1 |
| Jesus, WR | 1 |
| Moreira, ED | 1 |
| Morris, M | 1 |
| Krieger, EM | 1 |
| Queiroz, MS | 1 |
| Shao, Y | 1 |
| Ismail-Beigi, F | 1 |
| González-Cuello, A | 1 |
| Milanés, MV | 1 |
| Aviles, M | 1 |
| Laorden, ML | 1 |
| Kondo, H | 1 |
| Nifuji, A | 1 |
| Takeda, S | 1 |
| Ezura, Y | 1 |
| Rittling, SR | 1 |
| Denhardt, DT | 1 |
| Nakashima, K | 1 |
| Karsenty, G | 1 |
| Noda, M | 1 |
| Yoshiyama, Y | 2 |
| Kanke, M | 2 |
| Leposavić, G | 1 |
| Arsenović-Ranin, N | 1 |
| Radojević, K | 1 |
| Kosec, D | 1 |
| Pesić, V | 2 |
| Vidić-Danković, B | 1 |
| Plećas-Solarović, B | 1 |
| Pilipović, I | 1 |
| Das, VA | 1 |
| Robinson, R | 1 |
| Paulose, CS | 1 |
| Kumar, R | 1 |
| Sharma, S | 1 |
| Zhang, W | 1 |
| Kanehara, M | 1 |
| Zhang, Y | 1 |
| Wang, X | 1 |
| Ishida, T | 1 |
| Marenzana, M | 1 |
| De Souza, RL | 1 |
| Chenu, C | 1 |
| Hsieh, PS | 1 |
| Hong, LZ | 1 |
| Furberg, C | 2 |
| Mosley, C | 1 |
| O'Connor, DT | 1 |
| Taylor, A | 1 |
| Slutsky, RA | 1 |
| Cervenka, J | 1 |
| Weber, MA | 3 |
| Drayer, JI | 4 |
| Fritschka, E | 1 |
| Distler, A | 1 |
| Gotzen, R | 1 |
| Thiede, HM | 1 |
| Philipp, T | 1 |
| Swann, AC | 1 |
| Mitchell, HC | 1 |
| Pettinger, WA | 1 |
| Donta, I | 1 |
| Karayannacos, PE | 1 |
| Boudoulas, H | 1 |
| Kostakis, A | 1 |
| Sechas, M | 1 |
| Varonos, D | 1 |
| Scalkeas, GR | 1 |
| Pertseva, MN | 1 |
| Kuznetzova, LA | 1 |
| Mazina, TI | 1 |
| Plesneva, SA | 1 |
| Arch, JR | 1 |
| Ainsworth, AT | 1 |
| Kato, H | 1 |
| Kurihara, J | 1 |
| Takata, Y | 1 |
| Kunugi, H | 1 |
| Miyajima, Y | 1 |
| Hayes, PC | 1 |
| Stewart, WW | 1 |
| Bouchier, IA | 1 |
| Bauer, JH | 1 |
| Alpert, MA | 1 |
| Dusseau, JW | 1 |
| Hutchins, PM | 1 |
| Igawa, T | 1 |
| Ikezono, K | 1 |
| Watanabe, K | 1 |
| Kimura, Y | 1 |
| Hedberg, A | 1 |
| Isaksson, O | 1 |
| Lundgren, B | 1 |
| Iwatsuki, K | 1 |
| Stein, PM | 1 |
| Hassanein, RS | 1 |
| Lukert, BP | 1 |
| Hashimoto, H | 1 |
| Ogawa, K | 1 |
| Oelkers, W | 1 |
| Köhler, A | 1 |
| Belkien, L | 1 |
| Fuchs-Hammoser, R | 1 |
| Maiga, M | 1 |
| Scherer, B | 1 |
| Weber, PC | 1 |
| Welle, S | 2 |
| Campbell, RG | 2 |
| Staessen, J | 4 |
| Fagard, R | 4 |
| Lijnen, P | 4 |
| Verschueren, LJ | 1 |
| Amery, A | 4 |
| Mills, PR | 1 |
| Rae, AP | 1 |
| Farah, DA | 1 |
| Russell, RI | 1 |
| Lorimer, AR | 1 |
| Carter, DC | 1 |
| Manohar, M | 1 |
| Thurmon, JC | 1 |
| Tranquilli, WJ | 1 |
| Devous, MD | 1 |
| Theodorakis, MC | 1 |
| Shawley, RV | 1 |
| Feller, DL | 1 |
| Benson, JG | 1 |
| Webster, J | 2 |
| Petrie, JC | 1 |
| McLean, I | 1 |
| Hawksworth, GM | 1 |
| Terao, N | 1 |
| Shen, DD | 1 |
| Jennings, AS | 1 |
| Saberi, M | 1 |
| Reeves, RA | 1 |
| Boer, WH | 1 |
| DeLeve, L | 1 |
| Leenen, FH | 2 |
| Helgeland, A | 1 |
| Leren, P | 1 |
| Foss, OP | 1 |
| Hjermann, I | 1 |
| Holme, I | 1 |
| Lund-Larsen, PG | 1 |
| Francès, H | 1 |
| Lecrubier, Y | 1 |
| Puech, AJ | 1 |
| Simon, P | 1 |
| MacGregor, GA | 2 |
| Markandu, ND | 2 |
| Banks, RA | 1 |
| Bayliss, J | 1 |
| Roulston, JE | 1 |
| Jones, JC | 1 |
| Hervey, GR | 1 |
| Tobin, G | 2 |
| Jurney, TH | 1 |
| Smallridge, RC | 1 |
| Routledge, PA | 1 |
| Shand, DG | 3 |
| Wartofsky, L | 1 |
| Hunyor, SN | 1 |
| Bauer, GE | 1 |
| Ross, M | 1 |
| Larkin, H | 1 |
| Watanabe, Y | 1 |
| Sokabe, H | 3 |
| Watanabe, TX | 1 |
| Richer, C | 1 |
| Venturini-Souto, N | 1 |
| Boissier, JR | 2 |
| Giudicelli, JF | 2 |
| Steffens, AB | 1 |
| Bertin, A | 1 |
| Harri, M | 1 |
| Haroutunian, V | 1 |
| Campbell, BA | 1 |
| Feely, J | 4 |
| Stevenson, IH | 2 |
| Crooks, J | 4 |
| Gonyea, WJ | 1 |
| Diepstra, G | 2 |
| Muntz, KH | 1 |
| Mitchell, JH | 2 |
| Evemy, KL | 1 |
| Cummins, P | 1 |
| Littler, WA | 1 |
| Vander Elst, E | 1 |
| Dombey, SL | 1 |
| Lawrence, J | 1 |
| Vlassak, W | 1 |
| Wexler, BC | 1 |
| McMurtry, JP | 1 |
| Llanos, AJ | 1 |
| Green, JR | 1 |
| Creasy, RK | 1 |
| Rudolph, AM | 2 |
| Gonyea, W | 1 |
| Forrest, A | 1 |
| Gunn, A | 1 |
| Hamilton, W | 1 |
| Stevenson, I | 1 |
| Watkins, J | 1 |
| Abbott, EC | 1 |
| Hensby, CN | 1 |
| Dollery, CT | 1 |
| Unkila, M | 1 |
| Pohjanvirta, R | 1 |
| MacDonald, E | 2 |
| Tuomisto, J | 1 |
| Yoshida, T | 1 |
| Sakane, N | 1 |
| Wakabayashi, Y | 1 |
| Yoshioka, K | 1 |
| Umekawa, T | 1 |
| Kondo, M | 1 |
| Holmäng, A | 2 |
| Jennische, E | 2 |
| Björntorp, P | 2 |
| Nagano, T | 1 |
| O'Harrow, S | 1 |
| Sponer, G | 1 |
| Zimmer, HG | 1 |
| Liverini, G | 1 |
| Iossa, S | 1 |
| Lionetti, L | 1 |
| Mollica, MP | 1 |
| Barletta, A | 1 |
| Dunnett, CW | 1 |
| Tamhane, AC | 1 |
| Koo, HP | 1 |
| Macarak, EJ | 1 |
| Zderic, SA | 1 |
| Duckett, JW | 1 |
| Synder, HM | 1 |
| Levin, RM | 1 |
| Veksler, VI | 1 |
| Levitskaya, EL | 1 |
| Khatkevich, AN | 1 |
| Orekhova, IV | 1 |
| Khuchua, ZA | 1 |
| Kapelko, VI | 1 |
| Zavanella, T | 2 |
| Radaelli, G | 2 |
| Girotti, P | 1 |
| Arias, E | 1 |
| Ameri, L | 1 |
| Presta, M | 1 |
| Mazzoleni, G | 1 |
| Ragnotti, G | 2 |
| Igbo, IN | 1 |
| Reigel, CE | 1 |
| Greene, IM | 1 |
| Kenny, AD | 1 |
| Miller, ES | 1 |
| Klinger, JC | 1 |
| Akin, C | 1 |
| Koebel, DA | 1 |
| Sonnenfeld, G | 1 |
| Buemann, B | 1 |
| Astrup, AV | 1 |
| Levett, JM | 1 |
| Marinelli, CC | 1 |
| Lund, DD | 1 |
| Pardini, BJ | 1 |
| Nader, S | 1 |
| Scott, BD | 1 |
| Augelli, NV | 1 |
| Kerber, RE | 1 |
| Schmid, PG | 1 |
| Kingwell, BA | 1 |
| Krause, L | 1 |
| Julius, S | 2 |
| Vorobioff, J | 1 |
| Picabea, E | 1 |
| Gamen, M | 1 |
| Villavicencio, R | 1 |
| Bordato, J | 1 |
| Bessone, F | 1 |
| Tanno, H | 1 |
| Palazzi, J | 1 |
| Sarano, H | 1 |
| Pozzoli, L | 1 |
| Kiba, T | 1 |
| Tanaka, K | 2 |
| Hoshino, M | 1 |
| Numata, K | 1 |
| Inoue, S | 1 |
| Ramos-Dias, JC | 1 |
| Yateman, M | 1 |
| Camacho-Hübner, C | 1 |
| Grossman, A | 1 |
| Lengyel, AM | 1 |
| Ostman-Smith, I | 1 |
| Roe, S | 1 |
| Cooper, AL | 1 |
| Morris, ID | 1 |
| Rothwell, NJ | 3 |
| Asztély, A | 1 |
| Ekman, R | 1 |
| Ekström, J | 1 |
| Head, A | 1 |
| Kendall, MJ | 1 |
| Ferner, R | 1 |
| Eagles, C | 1 |
| Barone, FC | 1 |
| Nelson, AH | 1 |
| Ohlstein, EH | 1 |
| Willette, RN | 1 |
| Sealey, JE | 1 |
| Laragh, JH | 3 |
| Campbell, WG | 1 |
| Feuerstein, GZ | 1 |
| Kuo, CH | 1 |
| Ding, Z | 1 |
| Ivy, JL | 1 |
| Gilson, TL | 1 |
| Kennedy, AD | 1 |
| Rampersand, T | 1 |
| Jacobs, G | 1 |
| Whittem, T | 1 |
| Sams, R | 1 |
| Calvert, C | 1 |
| Ferguson, D | 1 |
| Sun, Z | 1 |
| Cade, JR | 1 |
| Fregly, MJ | 1 |
| Rowland, NE | 1 |
| Karasu, C | 1 |
| Ozansoy, G | 1 |
| Bozkurt, O | 1 |
| Erdoğan, D | 1 |
| Omeroğlu, S | 1 |
| Sugiyama, T | 1 |
| Miyazaki, H | 1 |
| Shimada, H | 1 |
| Takahashi, W | 1 |
| Wada, Y | 1 |
| Goto, S | 1 |
| Inadome, A | 1 |
| Yono, M | 1 |
| Ueda, S | 1 |
| Prendergast, BJ | 1 |
| Zucker, I | 1 |
| Yellon, SM | 1 |
| Ringold, DA | 1 |
| Gorman, MR | 1 |
| Dimmitt, SB | 1 |
| Williams, PD | 1 |
| Croft, KD | 1 |
| Beilin, LJ | 2 |
| Sumanovski, LT | 1 |
| Battegay, E | 1 |
| Stumm, M | 1 |
| van der Kooij, M | 1 |
| Sieber, CC | 1 |
| Latour, MG | 1 |
| Brault, A | 1 |
| Huet, PM | 1 |
| Lavoie, JM | 1 |
| Le Couteur, DG | 1 |
| Hickey, H | 1 |
| Harvey, PJ | 1 |
| Gready, J | 1 |
| McLean, AJ | 1 |
| Cardani, R | 1 |
| Hack, JB | 1 |
| Leviss, JA | 1 |
| Nelson, LS | 1 |
| Hoffman, RS | 1 |
| Coppes, RP | 1 |
| Roffel, AF | 1 |
| Zeilstra, LJ | 1 |
| Vissink, A | 1 |
| Konings, AW | 1 |
| Plećas, B | 1 |
| Lalić, N | 1 |
| Solarović, T | 1 |
| Hristić, M | 1 |
| Picard, F | 1 |
| Richard, D | 1 |
| Timofeeva, E | 1 |
| Deshaies, Y | 1 |
| Silva, CO | 1 |
| Monteiro-Filho, WO | 1 |
| Duarte, GP | 1 |
| Lahlou, S | 1 |
| Pacca, SR | 1 |
| de Azevedo, AP | 1 |
| De Oliveira, CF | 1 |
| De Luca, IM | 1 |
| De Nucci, G | 1 |
| Antunes, E | 1 |
| Turner, LR | 1 |
| Premo, DA | 1 |
| Gibbs, BJ | 1 |
| Hearthway, ML | 1 |
| Motsko, M | 1 |
| Sappington, A | 1 |
| Walker, L | 1 |
| Mullendore, ME | 1 |
| Chew, HG | 1 |
| Bengtsson, C | 3 |
| Weidmann, P | 2 |
| Beretta-Piccoli, C | 1 |
| Ziegler, W | 1 |
| Hirsch, D | 1 |
| de Châtel, RD | 1 |
| Reubi, FC | 1 |
| Tenore, A | 1 |
| Berman, WF | 1 |
| Parks, JS | 1 |
| Bongiovanni, AM | 1 |
| Collinge, J | 1 |
| Kern, MD | 1 |
| Redmond, DE | 1 |
| Swann, A | 1 |
| Heninger, GR | 1 |
| Sehrt, U | 1 |
| Weber, E | 1 |
| Delcayre, C | 1 |
| Swynghedauw, B | 1 |
| Keim, HJ | 1 |
| Case, DB | 2 |
| Frölich, JC | 1 |
| Hollifield, JW | 1 |
| Michelakis, AM | 1 |
| Vesper, BS | 1 |
| Wilson, JP | 1 |
| Seyberth, HJ | 1 |
| Frölich, WH | 1 |
| Oates, JA | 1 |
| Wilkinson, PR | 1 |
| Raftery, EB | 1 |
| Keusch, GW | 1 |
| Campese, V | 1 |
| Lee, DB | 1 |
| Upham, AT | 1 |
| Massry, SG | 1 |
| Mazurkiewicz-Kwilecki, IM | 1 |
| Isles, TE | 1 |
| Ratcliffe, WA | 1 |
| Hicks, PE | 1 |
| O'Dea, K | 1 |
| Tank, C | 1 |
| Kaplovitz, H | 1 |
| Marino, AJ | 1 |
| Owens, CJ | 1 |
| Brackett, NC | 1 |
| Klopfenstein, HS | 1 |
| Schoenfeld, N | 2 |
| Epstein, O | 2 |
| Nemesh, L | 1 |
| Rosen, M | 2 |
| Atsmon, A | 2 |
| Nishiyama, K | 1 |
| Nishiyama, A | 1 |
| Pfeffer, MA | 1 |
| Frohlich, ED | 2 |
| Oh, MS | 1 |
| Carroll, HJ | 1 |
| Altman, J | 1 |
| Gordan, P | 1 |
| Grünfeld, JP | 1 |
| Fichman, MP | 1 |
| Telfer, N | 1 |
| Zia, P | 1 |
| Speckart, P | 1 |
| Golub, M | 1 |
| Rude, R | 1 |
| Ryan, JR | 1 |
| Jain, AK | 1 |
| McMahon, FG | 1 |
| Kunos, G | 1 |
| Swan, KG | 1 |
| Kerr, JC | 1 |
| Wright, CB | 1 |
| Reynolds, DG | 1 |
| Lopez-Ovejero, JA | 1 |
| Wilson, DE | 1 |
| Jubiz, W | 1 |
| Flowers, CM | 1 |
| Carlile, SI | 1 |
| Adolf, AM | 1 |
| Sparks, JC | 1 |
| Susic, D | 1 |
| Bartolomé, J | 1 |
| Lau, C | 1 |
| Slotkin, TA | 2 |
| Goulding, A | 1 |
| McChesney, R | 1 |
| Stewart, RD | 1 |
| Warren, DJ | 2 |
| Ledingham, JG | 1 |
| Ohrn, PG | 1 |
| Rentzhog, L | 1 |
| Bray, GA | 1 |
| Campfield, LA | 1 |
| Geyskes, GG | 1 |
| Boer, P | 1 |
| Vos, J | 1 |
| Mees, EJ | 1 |
| Kloppenborg, PW | 1 |
| Festen, J | 1 |
| van't Laar, A | 1 |
| Benraad, TJ | 1 |
| Brundin, T | 1 |
| Cernigliaro, C | 1 |
| Mazzaferri, EL | 1 |
| Reynolds, JC | 1 |
| Young, RL | 1 |
| Thomas, CN | 1 |
| Parisi, AF | 1 |
| Georges, LP | 1 |
| Santangelo, RP | 1 |
| Mackin, JF | 1 |
| Canary, JJ | 1 |
| Olefsky, J | 1 |
| Crapo, PA | 1 |
| Ginsberg, H | 2 |
| Reaven, GM | 2 |
| Eisenberg, RM | 1 |
| Fukiyama, K | 1 |
| Kumamoto, K | 1 |
| Yamamoto, Y | 1 |
| Oniki, H | 1 |
| Omae, T | 1 |
| Maggiore, Q | 1 |
| Biagini, M | 1 |
| Zoccali, C | 1 |
| Misefari, M | 1 |
| Wilson, JT | 1 |
| Atwood, GF | 1 |
| London, GM | 1 |
| Safar, ME | 1 |
| Weiss, YA | 1 |
| Milliez, PL | 1 |
| Choo, JJ | 1 |
| Horan, MA | 1 |
| Little, RA | 1 |
| Gawel, MJ | 1 |
| Kreeft, J | 1 |
| Nelson, RF | 1 |
| Simard, D | 1 |
| Arnott, WS | 1 |
| Erdtsieck-Ernste, EB | 2 |
| Feenstra, MG | 2 |
| Botterblom, MH | 1 |
| De Barrios, J | 1 |
| Boer, GJ | 2 |
| Kudlacz, EM | 1 |
| Spencer, JR | 1 |
| Schwartz, RG | 1 |
| Statt, M | 1 |
| van Galen, H | 1 |
| Speiser, Z | 1 |
| Gordon, I | 1 |
| Rehavi, M | 1 |
| Gitter, S | 1 |
| Gousse, A | 1 |
| Weiss, RM | 1 |
| Latifpour, J | 1 |
| Perret, G | 1 |
| Yin, YL | 1 |
| Nicolas, P | 1 |
| Vassy, R | 1 |
| Uzzan, B | 1 |
| Louchahi, M | 1 |
| Alsip, NL | 1 |
| Harris, PD | 1 |
| Kortelainen, ML | 1 |
| Huttunen, P | 1 |
| Lapinlampi, T | 1 |
| Bürgi, U | 1 |
| Bürgi-Saville, ME | 1 |
| Burgherr, J | 1 |
| Clément, M | 1 |
| Lauber, K | 1 |
| Celsing, F | 1 |
| Westing, SH | 1 |
| Adamson, U | 1 |
| Ekblom, B | 1 |
| Lupien, JR | 1 |
| Hirshman, MF | 1 |
| Horton, ES | 2 |
| Teshima, H | 1 |
| Sogawa, H | 1 |
| Kihara, H | 1 |
| Kubo, C | 1 |
| Mori, K | 1 |
| Nakagawa, T | 1 |
| Breitenstein, E | 1 |
| Chioléro, RL | 1 |
| Jéquier, E | 2 |
| Dayer, P | 1 |
| Krupp, S | 1 |
| Schutz, Y | 1 |
| el-Yazigi, A | 1 |
| el-Baage, T | 1 |
| al-Humaidan, A | 1 |
| Yusuf, A | 1 |
| Kishi, K | 2 |
| Kawashima, K | 2 |
| Saito, K | 1 |
| Fiocchi, R | 1 |
| Rorive, G | 3 |
| Blaton, V | 1 |
| Hollez, P | 1 |
| Smith, EF | 1 |
| Egan, JW | 1 |
| Griswold, DE | 1 |
| Shigematsu, S | 1 |
| Iwasaki, T | 1 |
| Aizawa, T | 1 |
| Ishihara, M | 1 |
| Shinoda, T | 1 |
| Yamada, T | 1 |
| Sato, A | 1 |
| Takemura, Y | 1 |
| Favier, RJ | 1 |
| Ghaemmaghami, F | 2 |
| Sempore, B | 1 |
| Desplanches, D | 2 |
| Mayet, MH | 1 |
| Frutoso, J | 1 |
| Gharib, C | 2 |
| Flandrois, R | 1 |
| Smith, SJ | 1 |
| Sagnella, GA | 1 |
| Schuna, AA | 1 |
| Vejraska, BD | 1 |
| Hiatt, JG | 1 |
| Kochar, M | 1 |
| Day, R | 1 |
| Goodfriend, TL | 1 |
| Kitami, Y | 1 |
| Hiwada, K | 1 |
| Kokubu, T | 1 |
| Nagamine, F | 1 |
| Murakami, K | 1 |
| Mimura, G | 1 |
| Sakanashi, M | 1 |
| Geller, HS | 1 |
| Nyhan, DP | 1 |
| Goll, HM | 1 |
| Clougherty, PW | 1 |
| Chen, BB | 1 |
| Murray, PA | 2 |
| Davidov, M | 1 |
| Abengowe, CU | 1 |
| Kubota, N | 1 |
| Ishii, Y | 1 |
| Kawase, S | 1 |
| Angerås, U | 4 |
| Oldfors, A | 1 |
| Hasselgren, PO | 4 |
| Harmon, JR | 1 |
| Delongchamp, RR | 1 |
| Kimmel, GL | 1 |
| Webb, PJ | 1 |
| Jagenburg, R | 2 |
| Lindstedt, G | 1 |
| Gelfand, RA | 1 |
| Hutchinson-Williams, KA | 1 |
| Bonde, AA | 1 |
| Castellino, P | 1 |
| Sherwin, RS | 1 |
| Ferrara, LA | 1 |
| Capaldo, B | 1 |
| Rivellese, A | 1 |
| Genovese, S | 1 |
| Iovine, C | 1 |
| Mastranzo, P | 1 |
| Cirillo, F | 1 |
| Mancini, M | 1 |
| Lodato, RF | 1 |
| Michael, JR | 1 |
| York, DA | 1 |
| Holt, SJ | 1 |
| Marchington, D | 1 |
| Vilos, GA | 1 |
| Challis, JR | 1 |
| Pliagas, GA | 1 |
| Lye, SL | 1 |
| Possmayer, F | 1 |
| Harding, PG | 1 |
| Janatová, T | 1 |
| Pelouch, V | 1 |
| Ostádal, B | 1 |
| Krause, EG | 1 |
| Hilakivi, LA | 1 |
| Taira, T | 1 |
| Hilakivi, I | 1 |
| Tuomisto, L | 1 |
| Hellevuo, K | 1 |
| Dowell, RT | 1 |
| Acheson, KJ | 1 |
| Ravussin, E | 2 |
| Schoeller, DA | 1 |
| Christin, L | 1 |
| Bourquin, L | 1 |
| Baertschi, P | 1 |
| Danforth, E | 2 |
| Byyny, RL | 1 |
| Nies, AS | 1 |
| LoVerde, ME | 1 |
| Mitchell, WD | 1 |
| Naukkarinen, VA | 1 |
| Karppinen, K | 1 |
| Sarna, S | 1 |
| Welle, SL | 1 |
| Seaton, TB | 1 |
| Flynn, FW | 1 |
| Berridge, KC | 1 |
| Grill, HJ | 1 |
| Butler, LG | 1 |
| Rogler, JC | 1 |
| Mehansho, H | 1 |
| Carlson, DM | 1 |
| Grzywa, M | 1 |
| Ji, LL | 1 |
| Doan, TD | 1 |
| Lennon, DL | 1 |
| Nagle, FJ | 1 |
| Lardy, HA | 1 |
| Stock, MJ | 1 |
| Tedstone, AE | 1 |
| Gauquelin, G | 1 |
| Allevard, AM | 1 |
| Favier, R | 1 |
| Augoyard, G | 1 |
| Wright, CE | 1 |
| Angus, JA | 1 |
| Johnson, GL | 1 |
| Ehrreich, SJ | 1 |
| el-Hage, AN | 1 |
| Balazs, T | 1 |
| Vaughan, MK | 1 |
| Joshi, BN | 1 |
| Reiter, RJ | 1 |
| Bowman, SL | 1 |
| Hudson, SA | 1 |
| Simpson, G | 1 |
| Munro, JF | 1 |
| Clements, JA | 1 |
| Thuresson-Klein, A | 1 |
| Moawad, AH | 1 |
| Hedqvist, P | 1 |
| Wahl, J | 1 |
| Turlapaty, P | 1 |
| Singh, BN | 1 |
| Tonooka, M | 1 |
| Kawashima, I | 1 |
| Sakashita, M | 1 |
| Yasuhara, H | 1 |
| Sakamoto, K | 1 |
| Simon, J | 1 |
| Leclercq, B | 1 |
| Bogardus, C | 1 |
| Schwartz, RS | 1 |
| Robbins, DC | 1 |
| Wolfe, RR | 1 |
| Sims, EA | 1 |
| Kassirer, JP | 1 |
| Kopelman, RI | 1 |
| Santoso, B | 1 |
| Ravid, M | 1 |
| Lang, R | 1 |
| Jutrin, I | 1 |
| Miller, JL | 1 |
| Ismail, F | 1 |
| Waligora, JK | 1 |
| Gevers, W | 1 |
| Koyal, SN | 1 |
| Stuart, RJ | 1 |
| Lundstrom, R | 1 |
| Thomas, V | 1 |
| Ellestad, MH | 1 |
| Hovell, MF | 1 |
| Geary, DC | 1 |
| Black, DR | 1 |
| Kamachi, K | 1 |
| Kirk, R | 1 |
| Elder, J | 1 |
| Krikler, DM | 1 |
| Lefevre, D | 1 |
| Lewis, B | 1 |
| Juel-Jensen, BE | 1 |
| Cotias, CT | 1 |
| de Santana, CF | 1 |
| Pinto, Kde V | 1 |
| Ludvigsson, J | 1 |
| Pierce, WS | 1 |
| Carter, DR | 1 |
| McGavran, MH | 1 |
| Waldhausen, JA | 1 |
| Azizi, F | 1 |
| Vagenakis, AG | 1 |
| Bush, JE | 1 |
| Braverman, LE | 1 |
| Williams, EM | 1 |
| Raine, AE | 1 |
| Stanton, HC | 2 |
| Mueller, RL | 1 |
| Allen, JA | 4 |
| Jenkinson, DJ | 1 |
| Roddie, IC | 4 |
| Lowe, DC | 2 |
| Wallace, WF | 1 |
| Klinge, EA | 1 |
| Willis, RJ | 1 |
| Kratzing, CC | 1 |
| Cicero, TJ | 1 |
| Meyer, ER | 1 |
| Bell, RD | 1 |
| Parratt, JR | 1 |
| Jose, AD | 1 |
| Collison, D | 1 |
| Hadden, DR | 1 |
| Montgomery, DA | 1 |
| Shanks, RG | 1 |
| Weaver, JA | 1 |
| Hagroo, AA | 1 |
| Verma, NP | 1 |
| Datta, P | 1 |
| Ajmani, NK | 1 |
| Vaishnava, H | 1 |
| Platt, DS | 1 |
| Cockrill, BL | 1 |
| Pals, DT | 1 |
| Fulton, RW | 1 |
| French, SW | 1 |
| Palmer, DS | 1 |
| Greenberg, S | 1 |
| George, WR | 1 |
| Kadowitz, PJ | 1 |
| Wilson, WR | 1 |
| Sannerstedt, R | 1 |
| Conway, J | 1 |
| Gottlieb, TB | 1 |
| Katz, FH | 1 |
| Chidsey, CA | 1 |
| Joffe, BI | 1 |
| Pimstone, BL | 1 |
| Riddle, MC | 1 |
| Schwartz, TB | 1 |
| Gala, RR | 1 |
| Janson, PA | 1 |
| Kuo, EY | 1 |
| Gregg, DE | 1 |
| Khouri, EM | 1 |
| Donald, DE | 1 |
| Lowensohn, HS | 1 |
| Pasyk, S | 1 |
| Mena, F | 1 |
| Reyes, G | 1 |
| Aguayo, D | 1 |
| Grosvenor, CE | 1 |
| Shoeman, DW | 1 |
| Sirtori, CR | 1 |
| Azarnoff, DL | 1 |
| Palmer, HM | 1 |
| Beardwell, CG | 1 |
| Hesse, B | 1 |
| Bollerup, AC | 1 |
| Olesen, KH | 1 |
| Okabe, S | 1 |
| Takeuchi, K | 1 |
| Honda, K | 1 |
| Takagi, K | 1 |
| Stasiewicz, J | 1 |
| Szalaj, W | 1 |
| Chmielewski, J | 1 |
| Gabryelewicz, A | 1 |
| Sewell, WH | 1 |
| Cheah, JS | 1 |
| Mendelson, JH | 1 |
| Rossi, AM | 1 |
| Bernstein, JG | 1 |
| Kuehnle, J | 1 |
| Heterington, DJ | 1 |
| Comerford, MB | 1 |
| Nyberg, G | 1 |
| Besterman, EM | 1 |
| Maksud, MG | 1 |
| Coutts, KD | 1 |
| Tristani, FE | 1 |
| Dorchak, JR | 1 |
| Barboriak, JJ | 1 |
| Hamilton, LH | 1 |
| Hyman, AI | 1 |
| Haworth, G | 1 |
| Bowe, ET | 1 |
| Daniel, SS | 1 |
| James, LS | 1 |
| Lundberg, A | 1 |
| Varma, S | 1 |
| Rakusan, K | 1 |
| Cowan, JS | 1 |
| Hetenyi, G | 1 |
| Matts, SG | 1 |
| Truccone, NJ | 1 |
| Levine, OR | 1 |
| Vávra, I | 1 |
| Tom, H | 1 |
| Greselin, E | 1 |
| Smith, CS | 1 |
| Howard, NJ | 1 |
| Bertin, MC | 1 |
| Molnar, GW | 1 |
| Read, RC | 1 |
| Swainson, CP | 1 |
| Wright, N | 1 |
| Avruskin, TW | 1 |
| Tang, SC | 1 |
| Juan, CS | 1 |
| Olefsky, JM | 1 |
| Martin, WR | 1 |
| Eades, CG | 1 |
| Thompson, WO | 1 |
| Thompson, JA | 1 |
| Flanary, HG | 1 |
| Richardson, DW | 1 |
| Freund, J | 1 |
| Gear, AS | 1 |
| Mauck, HP | 1 |
| Preston, LW | 1 |
| Pimstone, B | 1 |
| Joffe, B | 1 |
| Pimstone, N | 1 |
| Bonnici, F | 1 |
| Jackson, WP | 1 |
| Lichtlen, P | 1 |
| Baumann, PC | 1 |
| Kobayakawa, T | 1 |
| Pirrelli, A | 1 |
| De Cesaris, R | 1 |
| Bayliss, RI | 1 |
| Edwards, OM | 1 |
| Fukuda, M | 1 |
| Yelnosky, J | 1 |
| Panasevich, RE | 1 |
| Borrelli, AR | 1 |
| Lawlor, RB | 1 |
| van Buchem, FS | 1 |
| Drion, EF | 1 |
| Wigbout, M | 1 |
| Bosschieter, E | 1 |
| Anton, AH | 1 |
| Gravenstein, JS | 1 |
| Dustan, HP | 1 |
| Tarazi, RC | 1 |
| Imre, S | 1 |
| von Schmalensee, G | 1 |
| Stout, BD | 1 |
| Wiener, L | 1 |
| Cox, JW | 1 |
| Smith, JE | 1 |
| Kako, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validation of a Novel Screening Test for Maternal Insulin Resistance and Predicting Maternal Fetal Outcomes: A Pilot Study.[NCT03388697] | 100 participants (Actual) | Observational | 2017-12-15 | Completed | |||
| Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation[NCT05351333] | 66 participants (Anticipated) | Interventional | 2022-08-03 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for propranolol and Body Weight
| Article | Year |
|---|---|
The part played by variation of energy expenditure in the regulation of energy balance.
Topics: Animals; Body Composition; Body Weight; Calorimetry, Indirect; Diet; Dietary Fats; Energy Intake; En | 1982 |
Minoxidil therapy in refractory hypertension analysis of 155 patients.
Topics: Adult; Animals; Body Weight; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrichosis | 1978 |
Role of prostaglandins in the pathogenesis of Bartter's syndrome.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Body Composition; Body Weight; Chi | 1976 |
Metabolic factors in the control of energy stores.
Topics: Adult; Age Factors; Animals; Basal Metabolism; Body Weight; Calorimetry; Computers; Diet; Energy Tra | 1975 |
Dietary effects of tannins.
Topics: Adaptation, Physiological; Animals; Body Weight; Chickens; Cricetinae; Diet; Dietary Proteins; Edibl | 1986 |
49 trials available for propranolol and Body Weight
| Article | Year |
|---|---|
Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Blood Glucose; Body Height; Body Weight; Child; C | 2016 |
Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Double-Blind Method; Guanabenz; G | 1984 |
Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
Topics: Adult; Blood Pressure; Body Weight; Calcium Channel Blockers; Catecholamines; Humans; Hypertension; | 1984 |
Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease.
Topics: Adipose Tissue; Body Weight; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1984 |
Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK).
Topics: Adult; Blood Pressure; Body Weight; Dipeptides; Double-Blind Method; Enalapril; Female; Humans; Hype | 1984 |
Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
Topics: Bendroflumethiazide; Body Weight; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Res | 1983 |
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperte | 1984 |
Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Weight; Drug Therapy, Combination; Fasting; Huma | 1984 |
Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Heart Rate; | 1982 |
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
Topics: Adult; Aged; Aldosterone; Body Weight; Captopril; Clinical Trials as Topic; Drug Therapy, Combinatio | 1982 |
Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Ethanolamines; Female; Humans; | 1980 |
Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Furosemide; Heart Rate; | 1981 |
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
Topics: Adult; Aged; Benzothiadiazines; Body Weight; Diuretics; Double-Blind Method; Female; Humans; Hyperte | 1980 |
Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Topics: Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Hemod | 1993 |
Acute effects of beta blockade and exercise on mood and anxiety.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Age Factors; Anxiety; Body Weight; Confusion; Depression | 1996 |
Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Cholesterol, HDL; C | 1998 |
Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Body Weight; Clinical Trials as Topic; Depression, Chem | 1976 |
[Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Benzofurans; Blood Pressure; Blood Volume; Body Weight; Ca | 1976 |
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Cycloox | 1979 |
A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Clonidine; Double-Blind Method; | 1977 |
The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension.
Topics: Adult; Aged; Aldosterone; Body Weight; Chlorothiazide; Drug Therapy, Combination; Female; Humans; Hy | 1978 |
Minoxidil treatment of severe hypertension.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Therapy, Combination; Elect | 1975 |
Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Bromine; Chlorthalidone; Clinical Trials as Topic; Diet, S | 1975 |
Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Creatinin | 1975 |
The effect of physical training on the sympathoadrenal response to exercise.
Topics: Adult; Body Height; Body Weight; Clinical Trials as Topic; Creatinine; Diuresis; Epinephrine; Heart | 1975 |
Propranolol as primary therapy for thyrotoxicosis.
Topics: Adult; Body Composition; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperthy | 1976 |
Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Body Weight; Canada; Double-Blind Method; Female; Flunarizine; Hemodynamics | 1992 |
Double-blind comparison of ketanserin with propranolol in hypertensive patients: interim report.
Topics: Adult; Aged; Antihypertensive Agents; Body Weight; Clinical Trials as Topic; Double-Blind Method; Fe | 1985 |
Serum cholesterol during ketanserin and propranolol administration in hypertensive patients.
Topics: Body Weight; Cholesterol; Female; Heart Rate; Humans; Hypertension; Ketanserin; Lipoproteins, HDL; L | 1987 |
Double-blind comparison of ketanserin and propranolol in hypertensive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Body Weight; Chromatography, High | 1988 |
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
Topics: Blood Pressure; Body Weight; Captopril; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hype | 1985 |
Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Topics: Blood Pressure; Blood Urea Nitrogen; Body Weight; Clinical Trials as Topic; Creatinine; Drug Interac | 1989 |
Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Clinical Trials as Topic; Double- | 1985 |
A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Black People; Blood Pressure; Body Weight; Dos | 1985 |
Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure.
Topics: Adult; Blood Pressure; Body Composition; Body Weight; Catecholamines; Clinical Trials as Topic; Diet | 1988 |
A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Dou | 1987 |
Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Huma | 1987 |
Comparison of acebutolol and propranolol in essential hypertension.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Blood Pressure; Body Weight; Clinical Trials as To | 1985 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparation | 1985 |
Alpha and beta adrenergic blockade in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Body Weight; Clini | 1972 |
Letter: Propranolol in treatment of migraine in children.
Topics: Adolescent; Body Weight; Child; Humans; Migraine Disorders; Propranolol | 1973 |
Observations on lipolysis in ketosis-resistant, growth-onset diabetes.
Topics: Adolescent; Adult; Blood Glucose; Body Height; Body Weight; Child; Climate; Clinical Trials as Topic | 1974 |
Comparison between alprenolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Topics: Adult; Alprenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans | 1972 |
Comparison between reserpine and propranolol as adjuncts in the treatment of hyperthyroidism.
Topics: Administration, Oral; Adult; Asthma; Basal Metabolism; Blood Pressure; Body Weight; Clinical Trials | 1973 |
Long-term effect of alprenolol as antihypertensive agent.
Topics: Adult; Airway Obstruction; Alprenolol; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials | 1974 |
Propranolol and behavior of alcohol addicts after acute alcohol ingestion.
Topics: Adult; Alcoholism; Analysis of Variance; Attention; Behavior; Body Weight; Breath Tests; Clinical Tr | 1974 |
Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
Topics: Adult; Aged; Alprenolol; Angina Pectoris; Blood Pressure; Body Weight; Clinical Trials as Topic; Dig | 1973 |
Effect of propranolol on elevated arterial blood pressure.
Topics: Adult; Aged; Antihypertensive Agents; Bilirubin; Blood Cell Count; Blood Pressure; Blood Urea Nitrog | 1968 |
Clinical response to long-term propranolol therapy in hyperthyroidism.
Topics: Adult; Body Weight; Clinical Trials as Topic; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; | 1969 |
278 other studies available for propranolol and Body Weight
| Article | Year |
|---|---|
Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Body Weight; Cell Line, Tumor; Cell | 2015 |
Beta blockade in TBI: Dose-dependent reductions in BBB leukocyte mobilization and permeability in vivo.
Topics: Animals; Blood-Brain Barrier; Body Weight; Brain Edema; Brain Injuries, Traumatic; Chronic Traumatic | 2022 |
Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two.
Topics: Body Height; Body Weight; Central Nervous System; Child; Child, Preschool; Drug-Related Side Effects | 2019 |
Sexual dimorphism in rats exposed to maternal high fat diet: alterations in medullary sympathetic network.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Body Weight; Diet, High-Fat; Female; Heart R | 2021 |
Mechanical mandible competence in rats with nutritional growth retardation.
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Disease | 2017 |
The Time Point-Specific Effect of Beta-Adrenergic Blockade in Attenuating High Fat Diet-Induced Obesity and Bone Loss.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Meta | 2018 |
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Body Weight; Drug Administration Schedule; Drug D | 2018 |
Propranolol regulates ERK1/2 signaling pathway and promotes chronic wound healing in diabetic rats.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Body Weight; Diabetes Mellitus, Exper | 2019 |
Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas.
Topics: Adrenergic beta-Antagonists; Body Height; Body Weight; Child Development; Dose-Response Relationship | 2019 |
Chronic hypoxic incubation blunts thermally dependent cholinergic tone on the cardiovascular system in embryonic American alligator (Alligator mississippiensis).
Topics: Adrenergic beta-Antagonists; Alligators and Crocodiles; Animals; Atropine; Benzazepines; Blood Press | 2013 |
Propranolol, a β-adrenergic antagonist, attenuates the decrease in trabecular bone mass in high calorie diet fed growing mice.
Topics: Adrenergic Antagonists; Animals; Body Weight; Bone Density; Bone Marrow Cells; Bone Resorption; Diet | 2014 |
Dynamic resistance training decreases sympathetic tone in hypertensive ovariectomized rats.
Topics: Animals; Antihypertensive Agents; Atropine Derivatives; Autonomic Nervous System; Body Weight; Brady | 2015 |
Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Antineoplastic Agents; Body Weight; Cohort Studie | 2016 |
Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years.
Topics: Body Height; Body Weight; Case-Control Studies; Child Development; Child, Preschool; Female; Hemangi | 2016 |
The vestibular system is critical for the changes in muscle and bone induced by hypergravity in mice.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Body Weight; Bone Density; Hypergra | 2016 |
Parasympathetic response to acute stress is attenuated in young Zucker obese rats.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Blood Pressure; Body Weight; Bradycardia; Conditioni | 2008 |
Adverse effects of propranolol on reproductive function in adult male mice.
Topics: Animals; Body Weight; Epididymis; Estradiol; Female; Fertility; Male; Mice; Organ Size; Pregnancy; P | 2007 |
Exercise and adrenaline increase PGC-1{alpha} mRNA expression in rat adipose tissue.
Topics: Abdominal Fat; Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Epinephrine; Male; Mitocho | 2009 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut | 2009 |
Body fat mass reduction and up-regulation of uncoupling protein by novel lipolysis-promoting plant extract.
Topics: Adipocytes; Adipose Tissue, White; Adrenergic beta-Antagonists; Animals; Body Composition; Body Weig | 2009 |
Beta-adrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS.
Topics: Acetyl-CoA Carboxylase; Adrenergic beta-Antagonists; AMP-Activated Protein Kinases; Analysis of Vari | 2010 |
Effects of exercise on male copulatory behavior after beta-adrenoreceptor blockade.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; Catheterization; Copulation | 2009 |
Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry.
Topics: Adrenergic beta-Antagonists; Animals; Biometry; Body Composition; Body Weight; Fresh Water; Heart; L | 2009 |
Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cyclic AMP; DNA Primers; Echocardiography; Gene E | 2009 |
Mitochondrial biogenesis in adipose tissue: can exercise make fat cells 'fit'?
Topics: Abdominal Fat; Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Epinephrine; Male; Mitocho | 2009 |
Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Body Weight; Cytokines; Di | 2009 |
Role of beta-adrenergic receptors in the hyperphagic and hypermetabolic responses to dietary methionine restriction.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Body Composition; Body Weight; Energy Metaboli | 2010 |
Blockade of sympathetic b-receptors inhibits Porphyromonas gingivalis-induced alveolar bone loss in an experimental rat periodontitis model.
Topics: Acid Phosphatase; Adrenergic beta-Antagonists; Alveolar Bone Loss; Alveolar Process; Animals; Bacter | 2010 |
Ejaculatory dysfunction in streptozotocin-induced diabetic rats: the role of testosterone.
Topics: Androgens; Animals; Body Weight; Cocaine; Diabetes Mellitus, Experimental; Ejaculation; Female; Male | 2011 |
Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG).
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Blotting, Western; Body Weight; | 2012 |
Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG).
Topics: Adipocytes; Administration, Oral; Adrenergic beta-Antagonists; Animals; Body Temperature; Body Weigh | 2012 |
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Ca | 2013 |
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catechol | 2002 |
Behavioral and cardiovascular changes in the chronic mild stress model of depression.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Blood Pressure; Body Weight; Chronic Disease | 2003 |
Effects of perinatal visual stimulation on preference, growth, and mortality in African clawed frogs (Xenopus Laevis).
Topics: Adrenergic beta-Antagonists; Animals; Arousal; Body Weight; Choice Behavior; Larva; Metamorphosis, B | 2003 |
Mitochondrial respiration in muscle and liver from cold-acclimated hypothyroid rats.
Topics: Adipose Tissue, Brown; Adrenergic Antagonists; Adrenergic Uptake Inhibitors; Animals; Body Weight; C | 2003 |
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Antagonists; Adr | 2004 |
Effect of beta-adrenoceptor blockade on cardiac activity in rats during postnatal ontogeny.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Body Weight; Electrophysiology; Femoral Vein; Heart Rat | 2003 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm | 2004 |
Exercise training changes autonomic cardiovascular balance in mice.
Topics: Animals; Atropine Derivatives; Autonomic Nervous System; Blood Pressure; Body Weight; Cardiovascular | 2004 |
Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle.
Topics: Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Body Weight; Captopril; Carrier Proteins | 2004 |
Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blotting, Western; Body Weight; Drug Administratio | 2004 |
Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.
Topics: Amino Acids; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Marrow Cells; Dopamine beta-Hydr | 2005 |
Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos.
Topics: Animals; Antithyroid Agents; Body Weight; Chick Embryo; Disopyramide; Drug Interactions; Hypothyroid | 2005 |
Characterization of thymocyte phenotypic alterations induced by long-lasting beta-adrenoceptor blockade in vivo and its effects on thymocyte proliferation and apoptosis.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Body Weight; CD4 Antigens; CD8 Antigens; Cell Proli | 2006 |
Enhanced beta-adrenergic receptors in the brain and pancreas during pancreatic regeneration in weanling rats.
Topics: Animals; Blood Glucose; Body Weight; Brain; DNA; Epinephrine; Insulin; Insulin Secretion; Islets of | 2006 |
Remodeling of extracellular matrix protein, collagen by beta-adrenoceptor stimulation and denervation in mouse gastrocnemius muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Body Weight; Collagen; Electrophores | 2006 |
Beta-blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats.
Topics: Acupuncture Therapy; Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Bone and Bon | 2007 |
Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice.
Topics: Adaptation, Physiological; Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Body Weight; Fem | 2007 |
Augmentation of nitric oxide is crucial for the time-dependent effects of rosiglitazone on blood pressure and baroreflex function in rats.
Topics: Administration, Oral; Animals; Arteries; Atropine Derivatives; Autonomic Nervous System; Baroreflex; | 2008 |
Adrenergic beta-blockade and physical working capacity.
Topics: Adult; Autonomic Nerve Block; Body Weight; Female; Heart Rate; Hemoglobinometry; Humans; Male; Physi | 1967 |
The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Weight; Calcium Channel Blockers; Drug Therapy, Combi | 1984 |
Caloric intake and Na+-K+-ATPase: differential regulation by alpha 1- and beta-noradrenergic receptors.
Topics: 4-Nitrophenylphosphatase; Adipose Tissue, Brown; Animals; Body Weight; Desipramine; Diet; Eating; En | 1984 |
Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Body Weight; Clonidine; Diastole; Diuretics; Female; Hu | 1981 |
Effect of beta-adrenergic blockade on physiologic growth in the Wistar rat.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Female; Growth; Male; Organ Size; Propranolol; Ra | 1982 |
Functional properties of catecholamine-sensitive adenylate cyclase system in embryonic chick skeletal muscle.
Topics: Adenylyl Cyclases; Animals; Body Weight; Catecholamines; Chick Embryo; Chickens; Cyclic AMP; Isoprot | 1982 |
Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats.
Topics: Adrenergic beta-Agonists; Animals; Body Composition; Body Temperature Regulation; Body Weight; Energ | 1983 |
Effects of prolonged administration of indenolol in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hyperte | 1983 |
Rapid reduction of severe hypertension with minoxidil.
Topics: Adult; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynami | 1980 |
Elevated arteriolar adenosine 3',5'-cyclic monophosphate production by SHR.
Topics: 1-Methyl-3-isobutylxanthine; Albuterol; Animals; Arterioles; Blood Pressure; Body Weight; Cyclic AMP | 1982 |
Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiomegaly; Carteolol; Dose-Response Relationship, Drug; Drinking; Heart Rat | 1984 |
Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats.
Topics: Aconitine; Animals; Arrhythmias, Cardiac; Body Weight; Eating; Heart; Humans; Male; Norepinephrine; | 1980 |
Effect of propranolol on prolyl hydroxylase activity in blood vessels of rats.
Topics: Animals; Ascorbic Acid; Blood Pressure; Blood Vessels; Body Weight; In Vitro Techniques; Iron; Male; | 1980 |
Predicting weight loss success among obese clients in a hospital nutrition clinic.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care Facilities; Body Weight; Estrogens, Conjugated | 1981 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial I | 1981 |
Studies on the mechanism by which ACTH stimulates renin activity and angiotensin II formation in man.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Body Weight; Circadian Rhythm; Diet | 1982 |
Stimulation of thermogenesis by carbohydrate overfeeding. Evidence against sympathetic nervous system mediation.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Body Weight; Dietary Carbohydrates; Epinephrin | 1983 |
Regional myocardial blood flow and coronary vascular reverse in unanesthetized vascular reserve in unanesthetized young calves with severe concentric right ventricular hypertrophy.
Topics: Animals; Blood Flow Velocity; Body Weight; Cardiomegaly; Cattle; Coronary Circulation; Heart Septum; | 1981 |
Flurbiprofen interaction with single doses of atenolol and propranolol.
Topics: Adult; Aldosterone; Atenolol; Blood Pressure; Body Weight; Female; Flurbiprofen; Heart Rate; Humans; | 1984 |
Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
Topics: Acute Kidney Injury; Animals; Biological Availability; Biotransformation; Blood Proteins; Blood Urea | 1983 |
Thyroid lymphoma in a patient with hyperthyroidism.
Topics: Body Weight; Female; Humans; Hyperthyroidism; Lymphoma; Middle Aged; Propranolol; Propylthiouracil; | 1984 |
Nonselective beta-blockade enhances pressor responsiveness to epinephrine, norepinephrine, and angiotensin II in normal man.
Topics: Adult; Angiotensin II; Blood Pressure; Body Weight; Drug Interactions; Epinephrine; Heart Rate; Huma | 1984 |
Evidence for the role of noradrenaline in some effects of quipazine.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Humans; Male; Methysergide; Mice; Norepinephrin | 1980 |
Propranolol decreases serum thyroxine as well as triiodothyronine in rats: a protein-binding effect.
Topics: Animals; Body Weight; Kidney; Liver; Male; Propranolol; Rats; Rats, Inbred Strains; Thyroidectomy; T | 1983 |
Combined effects of phenoxybenzamine and propranolol in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Body Weight; Heart Rate; Hypertension; Male; Phenoxybenzamine; Pro | 1980 |
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hype | 1980 |
The modulatory effect of the hypothalamus on glucagon and insulin secretion in the rat.
Topics: Animals; Blood Glucose; Body Weight; Glucagon; Hexamethonium Compounds; Hypothalamus; Insulin; Insul | 1981 |
Effect of propranolol on the secretory activity of Escherichia coli heat-stable enterotoxin in the suckling mouse assay.
Topics: Administration, Oral; Animals; Animals, Suckling; Body Weight; Drug Antagonism; Enterotoxins; Escher | 1982 |
Beta blockade and physical training in rats.
Topics: Animals; Blood Pressure; Body Temperature Regulation; Body Weight; Heart Rate; Metoprolol; Physical | 1982 |
Neural control of the heart-rate-orienting response in preweanling rats.
Topics: Animals; Arousal; Auditory Perception; Body Weight; Dopamine; Functional Laterality; Guanethidine; H | 1982 |
Increased clearance of propranolol in thyrotoxicosis.
Topics: Administration, Oral; Adult; Aged; Body Weight; Female; Half-Life; Humans; Hyperthyroidism; Kinetics | 1981 |
Cardiovascular response to static exercise in the conscious cat.
Topics: Animals; Atropine; Body Weight; Cardiovascular System; Cats; Heart Rate; Isometric Contraction; Phys | 1981 |
The effect of prolonged administration of propranolol and timolol on the growth and the heart of growing rabbits.
Topics: Animals; Body Weight; Eating; Growth; Heart; Heart Rate; Injections, Intraperitoneal; Injections, Su | 1981 |
Propranolol-induced alterations in the pathophysiology of spontaneously hypertensive rats.
Topics: Aging; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Corticosterone; F | 1981 |
Increased heart rate response to parasympathetic and beta adrenergic blockade in growth-retarded fetal lambs.
Topics: Animals; Atropine; Blood Gas Analysis; Blood Pressure; Body Weight; Female; Fetal Growth Retardation | 1980 |
Propranolol dynamics in thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Body Weight; Female; Heart Rate; Humans; Hyperthyroidism; Male; Middle Aged | 1980 |
Cardiovascular response to static exercise during selective autonomic blockade in the conscious cat.
Topics: Animals; Atropine; Autonomic Nerve Block; Blood Pressure; Body Weight; Cardiovascular System; Cats; | 1980 |
Propranolol dosage in thyrotoxicosis.
Topics: Adolescent; Adult; Body Weight; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypert | 1980 |
Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced brain serotonin metabolism in the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Body Weight; Brain Chemistry; Eating; Hydrazi | 1994 |
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese mice.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; An | 1994 |
The effects of long-term hyperinsulinaemia on insulin sensitivity in rats.
Topics: Animals; Blood Glucose; Body Weight; Deoxyglucose; Female; Glycogen; Hyperinsulinism; Insulin; Muscl | 1995 |
Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Carbazoles; Carvedilol; Female; Glucosephosphate | 1993 |
Sympathetically-mediated thermogenic response to food in rats.
Topics: Animals; Body Temperature Regulation; Body Weight; Energy Intake; Food; Hyperphagia; Kinetics; Male; | 1995 |
Step-up multiple testing of parameters with unequally correlated estimates.
Topics: Animals; Biometry; Body Weight; Captopril; Cardiovascular Physiological Phenomena; Cardiovascular Sy | 1995 |
The ontogeny of bladder function in the fetal calf.
Topics: Adenosine Triphosphate; Animals; Atropine; Bethanechol; Body Weight; Cattle; Electric Stimulation; F | 1995 |
Myocardial adaptation to long-term action of substances associated with decreased intensity of cardiac function.
Topics: Adaptation, Physiological; Adenosine Triphosphatases; Animals; Body Weight; Calcium; Heart; Hypothyr | 1994 |
Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.
Topics: Animals; Atenolol; Body Weight; Carcinogens; Diethylnitrosamine; Female; gamma-Glutamyltransferase; | 1994 |
Effect of reserpine pretreatment on avian erythrocyte carbonic anhydrase activation by isoproterenol.
Topics: Animals; Body Weight; Carbonic Anhydrases; Coturnix; Enzyme Activation; Erythrocytes; Isoproterenol; | 1994 |
Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-D-glucose-induced metabolic stress.
Topics: Adrenalectomy; Animals; Body Weight; Cell Survival; Corticosterone; Deoxyglucose; Female; Hypophysec | 1994 |
[Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight].
Topics: Adrenergic beta-Antagonists; Adult; Body Weight; Energy Metabolism; Exercise; Female; Humans; Obesit | 1993 |
Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Bicarbonates; Biomarkers; Body Weight; Car | 1994 |
The effect of hypertensive episodes and cardiac hypertrophy on the canine cardiac baroreflex.
Topics: Analysis of Variance; Animals; Baroreflex; Blood Pressure; Body Weight; Disease Models, Animal; Dogs | 1994 |
Comparison of DNA synthesis in white and brown adipose tissue in rats with ventromedial hypothalamic lesions.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Atropine; Body Weight; DNA; Feeding Behavior; Female | 1993 |
Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Body Composition; Body Weight; Case-Control Studies; | 1995 |
Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Aortic Coarctation; Bo | 1995 |
Mechanisms of cachexia induced by T-cell leukemia in the rat.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Body Weight; Cachexia; Food; Leukemia, | 1996 |
Rapid formation of capillary endothelial cells in rat skeletal muscle after exposure to insulin.
Topics: Adrenalectomy; Animals; Blood Glucose; Body Weight; Capillaries; Cell Division; Corticosterone; Endo | 1996 |
Depletion of vasoactive intestinal peptide and substance P in parotid glands of atropinized rats during reflex secretion.
Topics: Adrenergic Antagonists; Animals; Atropine; Body Weight; Capsaicin; Diet; Female; Neuropeptide Y; Org | 1996 |
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 1996 |
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C | 1996 |
Effects of breed and adipose depot location on responsiveness and sensitivity to adrenergic stimulation in ovine adipose tissue.
Topics: Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Varia | 1996 |
Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Algorithms; Animals; Area Under Curve; Body Weigh | 1997 |
Effect of chronic treatment with propranolol on the cardiovascular responses to chronic cold exposure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Cardiomegaly; Cold Temperature; H | 1997 |
Changes in isoprenaline-induced endothelium-dependent and -independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E.
Topics: Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Isoproterenol | 1997 |
Toxic interactions between disopyramide and propranolol in chick embryos.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Chick Embryo; Disopyramide; Drug Interactions; Electro | 1997 |
Effect of estrogen on nitric oxide-induced relaxation of the rabbit urethra.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atropine; Body Weight; Cardiotonic Age | 1997 |
Melatonin chimeras alter reproductive development and photorefractoriness in Siberian hamsters.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Chimera; Cricetinae; Female; Follicle Stimulating | 1998 |
Increased angiogenesis in portal hypertensive rats: role of nitric oxide.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Disease Models, Animal; Hypertension, Portal; Ima | 1999 |
Effects of acute physical exercise on hepatocyte volume and function in rat.
Topics: Animals; Bile; Body Weight; Cell Survival; Detergents; Fasting; Fatty Acids, Nonesterified; Glucagon | 1999 |
Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Topics: Animals; Body Weight; Hepatic Artery; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Male; | 1999 |
Influence of beta-adrenergic antagonists on cell proliferation rates in the kidney of untreated and diethylnitrosamine-treated male F344 rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carcinogens; Cell Division; Diethylnitr | 1999 |
Severe symptoms following a massive intentional L-thyroxine ingestion.
Topics: Adult; Antidotes; Body Weight; Charcoal; Diazepam; Haloperidol; Humans; Intubation, Intratracheal; M | 1999 |
Early radiation effects on muscarinic receptor-induced secretory responsiveness of the parotid gland in the freely moving rat.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Male; Methacholine Chloride; Muscarinic Agonists; | 2000 |
beta-Adrenergic receptor manipulation and acid phosphatase and zinc levels in the ventral prostate of the adult rat.
Topics: Acid Phosphatase; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory | 2000 |
Abnormal insulin and beta-adrenergic modulation of lipoprotein liipase during refeeding after prolonged fasting in the Zucker rat.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Fasting; Food Deprivation | 2000 |
Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Body Weig | 2001 |
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressu | 2002 |
Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Arteries; Body Weight; Cardiomegaly | 2002 |
Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease.
Topics: Adolescent; Animals; Body Height; Body Weight; Child; Colitis, Ulcerative; Crohn Disease; Female; Gl | 1977 |
The effects of thyroxine and propanolol on the metabolic rate of degus.
Topics: Animals; Body Weight; Drug Interactions; Epinephrine; Female; Kinetics; Male; Oxygen Consumption; Pr | 1979 |
Letter: Phenoxybenzamine in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Body Weight; Female; Humans; Phenoxybenzamine; Propranolol; Satiety Respons | 1976 |
[Basis of pharmaco-therapy. Clinical pharmacology in key words. Finding the dosage].
Topics: Age Factors; Body Weight; Dose-Response Relationship, Drug; Drug Therapy; Extracellular Space; Femal | 1979 |
Myosin synthesis and enzymatic properties during thyroxine intoxication in rabbits.
Topics: Animals; Body Weight; Calcium-Transporting ATPases; Cardiomegaly; Heart Rate; Hyperthyroidism; Male; | 1979 |
Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
Topics: Adult; Age Factors; Aldosterone; Blood Pressure; Body Weight; Depression, Chemical; Female; Heart Ra | 1976 |
Propranolol and brain histamine: acute and chronic effects.
Topics: Animals; Body Temperature; Body Weight; Brain Chemistry; Histamine; Male; Motor Activity; Propranolo | 1979 |
Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
Topics: Adolescent; Adult; Aged; Body Weight; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; Proprano | 1979 |
The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies.
Topics: Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Diuretics; Eating; Hypertension; Indapam | 1979 |
Development of insulin sensitivity in rat aorta after chronic propranolol treatment.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Chromatography, Thin Layer; Drug Interactions; Glucose; | 1978 |
Role of sodium intake in the antihypertensive effect of propranolol.
Topics: Adult; Blood Pressure; Blood Volume; Body Weight; Diet, Sodium-Restricted; Diuretics; Female; Humans | 1978 |
Postnatal changes in the circulation and responses to volume loading in sheep.
Topics: Animals; Animals, Newborn; Atropine; Blood Circulation; Blood Volume; Body Weight; Cardiac Output; F | 1978 |
Effects of propranolol during pregnancy and development of rats. I. Adverse effects during pregnancy.
Topics: Animals; Birth Weight; Body Weight; Dose-Response Relationship, Drug; Female; Fetus; Placenta; Pregn | 1978 |
Systemic and regional flow distribution in normotensive and spontaneously hypertensive young rats subjected to lifetime beta-adrenergic receptor blockade.
Topics: Animals; Body Weight; Cardiac Output; Coronary Circulation; Drinking; Female; Heart; Hemodynamics; H | 1978 |
[Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Furosemide; Hypertension; Male; Models, Biolog | 1976 |
Thyroid hormone-dependent interconversion of myocardial alpha- and beta-adrenoceptors in the rat.
Topics: Animals; Atrial Function; Body Weight; Calcium; Dose-Response Relationship, Drug; Heart; Heart Atria | 1977 |
Adrenergic mechanisms in the hepatic arterial circulation of baboons.
Topics: Animals; Blood Flow Velocity; Body Weight; Epinephrine; Hepatic Artery; Homeostasis; Isoproterenol; | 1977 |
Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorthalidone; Drug | 1977 |
Tissue lipoprotein lipase in the hyperthyroid rat. Effect of growth and aging.
Topics: Adipose Tissue; Aging; Animals; Body Weight; Diaphragm; Fasting; Female; Heart; Hyperthyroidism; Lip | 1977 |
The effects of propranolol on plasma renin activity and renal renin concentration in rats on normal and sodium deficient diets.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diet; Drug Interactions; Heart Rate; Kidn | 1977 |
Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation.
Topics: Adrenal Medulla; Aging; Animals; Animals, Newborn; Body Weight; Brain; Carboxy-Lyases; Chlorisondami | 1977 |
Letter: Propranolol therapy of hypertension.
Topics: Body Weight; Humans; Hypertension; Propranolol | 1976 |
Effects of propranolol on changes in heart rate, heart weight, kidney weight, urinary hydroxyproline and weight gain induced by large doses of thyroxine in the rat.
Topics: Animals; Body Weight; Carbimazole; Heart; Heart Rate; Hydroxyproline; Kidney; Male; Organ Size; Prop | 1976 |
Effects of beta-adrenergic receptor blockade on the renal vascular response to a low sodium diet in the rabbit.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Body Weight; Cardiac Output; Diet, Sodium-Restricted; | 1975 |
Effect of adrenergic blockade on gastrointestinal propulsion after laparotomy. An experimental study in the rat.
Topics: Abdomen; Animals; Body Weight; Gastrointestinal Motility; Intestine, Small; Male; Phenoxybenzamine; | 1976 |
Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, calcium, and hydroxyproline.
Topics: Adult; Body Weight; Calcium; Creatinine; Feces; Female; Humans; Hydroxyproline; Hyperthyroidism; Mal | 1975 |
Metabolic effects of increased caloric intake in man.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diet; Eating; Epinephrine; Fasting; Female; Glucose; | 1975 |
Further evidence of a central alpha-adrenergic inhibitory influence on the hypothalamo-pituitary-adrenal axis in the rat.
Topics: Adrenal Glands; Animals; Body Weight; Cerebral Ventricles; Corticosterone; Dexamethasone; Dopamine; | 1975 |
Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Furosemide; Humans; Hydralazine; Hypert | 1975 |
Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis.
Topics: Body Weight; Heart Rate; Humans; Hypertension, Renal; Propranolol; Renal Dialysis; Renin; Uremia | 1975 |
Disposition of propoxyphene and propranolol in children.
Topics: Adolescent; Age Factors; Biological Availability; Body Weight; Child; Child, Preschool; Dextropropox | 1976 |
Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Heart Rate; Humans; Hypertension; Isoproterenol; Ma | 1976 |
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.
Topics: Albuterol; Animals; Body Weight; Clenbuterol; Dose-Response Relationship, Drug; Male; Muscles; Organ | 1992 |
Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.
Topics: Animals; Animals, Newborn; Biogenic Amines; Body Weight; Brain; Labetalol; Organ Size; Propranolol; | 1992 |
Postnatal alterations in beta-adrenergic receptor binding in rat brain regions after continuous prenatal exposure to propranolol via maternal infusion.
Topics: Animals; Body Weight; Brain; Brain Stem; Cerebellum; Female; Infusions, Intravenous; Maternal-Fetal | 1991 |
Reduced metabolic rate during beta-adrenergic blockade in humans.
Topics: Adult; Analysis of Variance; Basal Metabolism; Blood Pressure; Body Weight; Humans; Male; Nadolol; P | 1991 |
Chronic propranolol treatment in developing rats: acute and lasting effects on monoamines and beta-adrenergic receptors in the rat brain.
Topics: Animals; Animals, Newborn; Biogenic Monoamines; Body Weight; Brain; Eye; Propranolol; Rats; Rats, In | 1991 |
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Avoidance Le | 1991 |
Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; D | 1991 |
In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5'-deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol.
Topics: Amiodarone; Animals; Anti-Bacterial Agents; Body Weight; Iodide Peroxidase; Liver; Macrolides; Male; | 1991 |
Receptor mediation of microvascular responses to serotonin in striated muscle.
Topics: Animals; Arterioles; Blood Pressure; Body Weight; Diphenhydramine; Male; Muscle, Smooth, Vascular; M | 1991 |
Influence of two beta-adrenoceptor antagonists, propranolol and pindolol, on cold adaptation in the rat.
Topics: Adaptation, Physiological; Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Body Tempera | 1990 |
T3 plus high doses of beta-blockers: effects on energy intake, body composition, bat and heart in rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Atenolol; Body Composit | 1990 |
Muscle strength in hyperthyroid patients before and after medical treatment.
Topics: Adult; Analysis of Variance; Body Weight; Female; Humans; Hyperthyroidism; Male; Methimazole; Muscle | 1990 |
Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness.
Topics: Animals; Blood Glucose; Body Weight; Feeding Behavior; Glucose; Glucose Clamp Technique; Glycogen; G | 1990 |
Prevention of immunosuppression in stressed mice by neurotropin(NSP).
Topics: Animals; Atropine; Body Weight; Cytotoxicity, Immunologic; Diazepam; Female; Immune Tolerance; Kille | 1990 |
Effects of beta-blockade on energy metabolism following burns.
Topics: Administration, Oral; Adult; Body Weight; Burns; Catecholamines; Energy Metabolism; Female; Heart Ra | 1990 |
Steady state pharmacokinetics of propranolol in Saudi Arabian patients and comparison with data for different populations.
Topics: Administration, Oral; Adult; Age Factors; Aged; Body Weight; Female; Homeostasis; Humans; Male; Midd | 1990 |
Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Blood Pressure; Body Weight; Heart Rate; Hyperten | 1985 |
Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Coronary Disease; Coronary Vessels; Heart Rate; | 1989 |
Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
Topics: Adolescent; Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Female | 1989 |
Skeletal muscle adaptation to physical training and beta-adrenergic blockade in spontaneously hypertensive rats.
Topics: Adaptation, Physiological; Animals; Blood Pressure; Body Weight; Hypertension; L-Lactate Dehydrogena | 1989 |
Kidney renin gene expression in spontaneously hypertensive rats.
Topics: Animals; Blotting, Northern; Body Weight; Captopril; Gene Expression; Hemodynamics; Kidney; Male; Pr | 1989 |
Effects of beta-adrenoceptor blocking agents on isolated atrial and papillary muscles from experimentally diabetic rats.
Topics: Animals; Atenolol; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relati | 1989 |
Combined neurohumoral block modulates pulmonary vascular P/Q relationship in conscious dogs.
Topics: Animals; Atropine; Autonomic Nervous System; Blood Pressure; Body Weight; Captopril; Cardiac Output; | 1988 |
Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension; Isoquin | 1985 |
The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Microscopy, El | 1986 |
Effect of prenatal propranolol exposure on development of the postnatal rat heart.
Topics: Age Factors; Animals; Animals, Newborn; Birth Weight; Body Weight; Female; Gestational Age; Heart; L | 1986 |
Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Histidine; Hyperthyroidism; Male; Methylhistidine | 1987 |
Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Hyperthyroidism; Male; Metoprolol; Muscle | 1987 |
Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Body Weight; Energy Intake; Energy Metabolism | 1987 |
Adrenergic system and carbohydrate metabolism. Effects of beta-receptor blockade on insulin secretion and peripheral insulin sensitivity in normoglycaemic patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Body Weight; Carbohydrate Metabol | 1987 |
Absence of neural modulation of hypoxic pulmonary vasoconstriction in conscious dogs.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Body Weight; Cardiac Output; Constriction; Dogs; | 1988 |
Regulation of brown adipose tissue thermogenesis by corticosterone in obese fa/fa rats.
Topics: Adipose Tissue, Brown; Adrenalectomy; Aldosterone; Animals; Body Temperature Regulation; Body Weight | 1985 |
Propranolol inhibits the maturational effect of adrenocorticotropin in the fetal sheep lung.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Female; Fetal Organ Maturity; Lun | 1985 |
The effect of oxidized isoprenaline on the chick embryonic heart.
Topics: Adrenochrome; Animals; Body Weight; Cardiomyopathies; Chick Embryo; Cyclic AMP; Isoproterenol; Myoca | 1986 |
Early postnatal treatment with propranolol affects development of brain amines and behavior.
Topics: Acoustic Stimulation; Aging; Alcohol Drinking; Animals; Animals, Newborn; Behavior, Animal; Biogenic | 1988 |
Postnatal development of rat heart during 6-hydroxydopamine or propranolol treatment.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Adenosine Triphosphatases; Age Factors; Animals; Body Weight; Crea | 1985 |
Specific dynamic action revisited: studies of hormonal regulation of energy expenditure in man.
Topics: Basal Metabolism; Body Weight; Epinephrine; Humans; Hyperphagia; Infusions, Intravenous; Norepinephr | 1988 |
Pre- and postabsorptive insulin secretion in chronic decerebrate rats.
Topics: Animals; Atropine; Body Weight; Brain Stem; Decerebrate State; Glucose; Hypothalamus; Insulin; Insul | 1986 |
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; P | 1986 |
The effects of beta-adrenergic blockade on body composition in free-fed and diet-restricted rats.
Topics: Adipose Tissue; Animals; Body Weight; Food Deprivation; Glycogen; Male; Propranolol; Rats; Rats, Inb | 1987 |
Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Body Weight; Eating; Energy Metabolism; | 1987 |
Attenuation by propranolol of exercise training effects in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hemodynamics; Hypertension; Male; Organ Siz | 1987 |
Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Body Weight; Female; Guanethidine; Heart Ra | 1986 |
Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Bretylium Tosylate; Death, Sudden; Disease Models, Ani | 1986 |
Daily propranolol administration reduces pineal concretion formation in the Mongolian gerbil.
Topics: Animals; Body Weight; Gerbillinae; Male; Pineal Gland; Propranolol | 1986 |
A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Body Weight; Female; Half-Life; Humans; Infusi | 1986 |
Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats.
Topics: Amino Acids; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Propranolol; Rats; Rats, Inbre | 1986 |
Estrogen stimulates formation of lamellar bodies and release of surfactant in the rat fetal lung.
Topics: Animals; Body Weight; Embryonic and Fetal Development; Estradiol; Female; Fetus; Gestational Age; Lu | 1985 |
Effect of chronic treatment of propranolol on lipid metabolism in spontaneously hypertensive rats (SHR).
Topics: Aging; Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fatty Acids, Nonesterified; | 1985 |
Fat and lean chickens: prefattening period and in vivo sensitivity to insulin, atropine, and propranolol.
Topics: Adipose Tissue; Animals; Atropine; Blood Glucose; Body Weight; Chickens; Diet; Fasting; Food; Glucos | 1985 |
Glucose-induced thermogenesis and insulin resistance in man.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Body Weight; Diabetes Mellitus; Diabetes Melli | 1985 |
A surprising cause of abdominal pain, anorexia, vomiting, and weight loss.
Topics: Abdomen; Anorexia; Body Weight; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; F | 1985 |
Effects of propranolol during pregnancy and development of rats. II. Adverse effects on development.
Topics: Animals; Animals, Newborn; Body Weight; Female; Lactation; Male; Pregnancy; Pregnancy, Animal; Propr | 1985 |
Impairment of isoniazid clearance by propranolol.
Topics: Adolescent; Adult; Body Weight; Humans; Isoniazid; Male; Metabolic Clearance Rate; Propranolol | 1985 |
Modulating influence of D,L-propranolol on triiodothyronine-induced skeletal muscle protein degradation.
Topics: Animals; Body Weight; Drug Interactions; Energy Intake; Male; Muscle Proteins; Muscles; Propranolol; | 1985 |
Does exercise alter anaerobic threshold in coronary artery disease during beta blockade?
Topics: Body Weight; Coronary Disease; Energy Metabolism; Female; Heart Function Tests; Humans; Male; Oxygen | 1985 |
Experimental analysis of adherence counseling: implications for hypertension management.
Topics: Adult; Behavior Therapy; Blood Pressure; Body Weight; Counseling; Follow-Up Studies; Humans; Hydroch | 1985 |
Dextrothyroxine with propranolol in treatment of hypercholesterolaemia.
Topics: Adult; Body Weight; Cholesterol; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Male; Middle | 1971 |
[Prevention of arrhythmia caused by chronic retamycin (complex) poisoning by using adrenergic blokaders].
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Body Weight; Chron | 1971 |
Modification of myocardial infarct volume. An experimental study in the dog.
Topics: Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Body Weight; Coronary Vessels; Disease Mode | 1973 |
Effect of propranolol on various aspects of thyroid function in the rat.
Topics: Administration, Oral; Animals; Body Weight; Infusions, Parenteral; Iodine Radioisotopes; Male; Metho | 1974 |
Effect of prolonged beta-receptor blockade on dry weight and electrophysiological responses of rabbit hearts.
Topics: Action Potentials; Animals; Body Water; Body Weight; Electrodes, Implanted; Heart; Injections, Subcu | 1974 |
Metabolic responses to cold and catecholamines as a function of age in swine (Sus domesticus).
Topics: Adrenal Glands; Aging; Animals; Animals, Newborn; Blood Glucose; Blood Pressure; Body Temperature Re | 1973 |
The effect of -adrenoceptor blockade on human sweating.
Topics: Adrenergic beta-Antagonists; Atropine; Body Weight; Emotions; Heart Rate; Hot Temperature; Humans; P | 1973 |
Studies on sweating in clinical and experimental thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Body Temperature; Body Weight; Cholesterol; Environment; Female; Heart | 1973 |
Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
Topics: Acetanilides; Adrenal Glands; Adrenergic beta-Antagonists; Allyl Compounds; Amino Alcohols; Animals; | 1971 |
Pulmonary ascorbic acid loss induced by catecholamines.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Body Weight; Bucl | 1974 |
Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Body Weight; Chlorpromazine; Depression, Che | 1974 |
The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; Cardiac Output | 1974 |
The normal range and determinants of the intrinsic heart rate in man.
Topics: Adolescent; Adult; Age Factors; Aged; Atropine; Blood Pressure; Body Temperature; Body Weight; Femal | 1970 |
Propranolol and radioactive iodine in the treatment of thyrotoxicosis.
Topics: Body Weight; Drug Synergism; Heart Rate; Humans; Hyperthyroidism; Hypothyroidism; Iodine Isotopes; P | 1970 |
Biochemical changes in rat liver in response to treatment with drugs and other agents. I. Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic beta-blocking agents.
Topics: Acetanilides; Aminopyrine; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticonvulsa | 1969 |
Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin II during the acute phase of experimental renal hypertension.
Topics: Alanine; Angiotensin II; Animals; Blood Pressure; Body Weight; Chlorisondamine; Guanethidine; Hypert | 1973 |
Adrenergic supersensitivity during ethanol withdrawal in the rat.
Topics: Animals; Body Weight; Cerebral Cortex; Cyclic AMP; Diet; Drug Hypersensitivity; Ethanol; Humans; Hyp | 1973 |
Androgen-induced enhancement of vascular reactivity.
Topics: Analysis of Variance; Androgens; Angiotensin II; Animals; Blood Pressure; Blood Vessels; Body Weight | 1974 |
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Body Height; Body Weigh | 1970 |
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Body Weight; Cardiac Output; Female; Fu | 1972 |
Selective metabolic and cardiovascular beta receptor antagonism in the rat.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Animals; Blood Glucose; Blood Pressure; B | 1972 |
New tactics for hyperthyroidism: sympathetic blockade.
Topics: Adrenergic beta-Antagonists; Body Weight; Humans; Hyperthyroidism; Propranolol; Sympatholytics; Time | 1970 |
The influence of neural blocking agents injected into the third ventricle of the rat brain and hypothalamic electrical stimulation on serum prolactin.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atropine; | 1972 |
Coronary circulation in the conscious dog with cardiac neural ablation.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cardiac Catheterization; Cardiac Output; Coronary | 1972 |
Effect of acute reduction in milk removal from some glands upon the ability of a single rabbit mammary gland to secrete milk.
Topics: Animals; Body Weight; Female; Injections, Subcutaneous; Lactation; Male; Mammary Glands, Animal; Mil | 1974 |
Inhibition of amphetamine tolerance and metabolism by propranolol.
Topics: Animals; Body Weight; Dextroamphetamine; Drug Tolerance; Kinetics; Male; Propranolol; Rats; Time Fac | 1974 |
Hyperthyroidism presenting with acute abdominal symptoms.
Topics: Abdomen, Acute; Adult; Antacids; Body Weight; Carbimazole; Colic; Diarrhea; Female; Goiter; Hemateme | 1974 |
The influence of beta-blocking agents on plasma volume and extracellular volume in ischaemic heart disease.
Topics: Adult; Aged; Blood Volume; Body Weight; Chromium Radioisotopes; Coronary Disease; Extracellular Spac | 1974 |
Effects of phentolamine mesylate and propranolol hydrochloride on aspirin-induced gastric lesions and gastric secretions in the rat.
Topics: Animals; Aspirin; Body Weight; Gastric Mucosa; Male; Phentolamine; Propranolol; Pylorus; Rats; Stoma | 1974 |
Effect of propranolol on the intestinal peristalsis in thyroxine treated mice.
Topics: Animals; Body Weight; Depression, Chemical; Gastrointestinal Motility; Hyperthyroidism; Male; Mice; | 1972 |
Improved coronary vein graft patency rates with side-to-side anastomoses.
Topics: Age Factors; Aged; Angiography; Anticoagulants; Blood Flow Velocity; Body Weight; Coronary Artery By | 1974 |
The effects of physical conditioning and propranolol on physical work capacity.
Topics: Adult; Body Weight; Cardiovascular Physiological Phenomena; Heart Rate; Humans; Male; Oxygen Consump | 1972 |
The role of circulating catecholamines in sweat production in man.
Topics: Adult; Atropine; Body Weight; Catecholamines; Dose-Response Relationship, Drug; Epinephrine; Female; | 1972 |
Effects of sympathetic blockade on the fetal responses to asphyxia.
Topics: Animals; Asphyxia; Blood Pressure; Body Weight; Carbon Dioxide; Constriction; Electrocardiography; F | 1972 |
Paroxysmal tachycardia in infancy: follow-up study of 47 subjects ranging in age from 10 to 26 years.
Topics: Adolescent; Adult; Age Factors; Angiocardiography; Body Height; Body Weight; Child; Digitalis; Elect | 1973 |
Stimulation of glucose production by hypoxia in newborn dogs.
Topics: Animals; Animals, Newborn; Blood Glucose; Body Weight; Dogs; Fatty Acids, Nonesterified; Glucose; He | 1973 |
Hypertension.
Topics: Antihypertensive Agents; Body Weight; Clonidine; Humans; Hypertension; Methyldopa; Propranolol; Smok | 1973 |
Cardiovascular effects of propranolol in intact puppies and adult dogs.
Topics: Animals; Animals, Newborn; Aorta; Blood Pressure; Body Weight; Cardiac Catheterization; Cardiac Outp | 1973 |
Chronic propranolol treatment in young spontaneously hypertensive and normotensive rats.
Topics: Adrenal Glands; Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hypertension; Kidney; Male; | 1973 |
Propranolol in treatment of neonatal thyrotoxicosis.
Topics: Administration, Oral; Body Weight; Female; Heart Rate; Humans; Hyperthyroidism; Infant, Newborn; Inf | 1973 |
[Quinidine-propranolol combination and ventricular tachycardia induced by ouabain].
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Ouabain; Propran | 1973 |
Propranolol enhancement of hypoglycemic sweating.
Topics: Adult; Aged; Blood Glucose; Body Weight; Electrocardiography; Heart Diseases; Humans; Hypoglycemia; | 1974 |
Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.
Topics: Adult; Body Weight; Creatinine; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Fail | 1974 |
Glucagon mediation of growth hormone secretion in juvenile diabetes mellitus.
Topics: Adolescent; Blood Glucose; Body Weight; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Growth H | 1974 |
Further evidence that insulin resistance exists in patients with chemical diabetes.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Epinephrine; Female; Glucose; Glucose Toleranc | 1974 |
Morphine physical dependence in the dog.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Dogs; Dose-Response Relationship, Drug; Ha | 1974 |
[On the treatment and diagnosis of angina pectoris].
Topics: Adult; Angina Pectoris; Angiocardiography; Anticholesteremic Agents; Anticoagulants; Body Weight; Di | 1969 |
Sweat production during catecholamine infusion in man.
Topics: Atropine; Body Temperature; Body Weight; Catecholamines; Heart Rate; Humans; Injections, Intravenous | 1972 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, | 1972 |
[Effect of propranolol on DOCA-induced experimental hypertension in rats].
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Desoxycorticosterone; Hematocrit; Hypertension | 1972 |
Urinary excretion of free catecholamines in Graves' disease.
Topics: Adult; Body Weight; Carbimazole; Catecholamines; Epinephrine; Female; Graves Disease; Heart Rate; Hu | 1971 |
The influence of isoprenaline and propranolol on the submaxillary gland of the rat.
Topics: Acetylcholinesterase; Animals; Body Weight; Female; Histocytochemistry; Isoproterenol; Monoamine Oxi | 1968 |
Pharmacology of phentermine.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Blood Pressure; Body Weight; Cardiovascular Sy | 1969 |
The clinical significance of an ST-segment depression in the electrocardiogram. A seven-year longitudinal study.
Topics: Adult; Aged; Angina Pectoris; Blood Circulation; Body Weight; Cholesterol; Coronary Disease; Coronar | 1969 |
Studies on thyroid-catecholamine interactions in the isolated rabbit heart.
Topics: Animals; Body Weight; Catecholamines; Cocaine; Drug Synergism; Epinephrine; Heart Atria; Heart Rate; | 1970 |
Hyperdynamic beta-adrenergic circulatory state. An overview.
Topics: Blood Circulation; Body Weight; Heart Rate; Hypertension; Isoproterenol; Propranolol; Receptors, Dru | 1970 |
Vagus pneumonia as membrane phospholipase activation.
Topics: Animals; Body Weight; Cytosol; Enzyme Activation; Fatty Acids, Nonesterified; Lung; Lysosomes; Organ | 1970 |
Beta-adrenergic blockade and central circulation during exercise in sitting position in healthy subjects.
Topics: Adult; Blood Circulation; Blood Gas Analysis; Blood Pressure; Body Weight; Brachial Artery; Cardiac | 1968 |
Combined alpha and beta sympathetic blockade in hyperthyroidism. Clinical and metabolic effects.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Body Weight; Cholesterol; Female; Humans; Hyperthyroidism; | 1969 |
Studies of amplitude variation in the ultra-low frequency ballistocardiogramwith special reference to cardiovascular reactivity.
Topics: Adult; Age Factors; Anxiety; Ballistocardiography; Body Height; Body Weight; Cardiac Output; Cardiov | 1969 |
The effect of a beta adrenergic blocking agent on chemical changes in isoproterenol-induced myocardial necrosis.
Topics: Adenine Nucleotides; Animals; Body Weight; Cholesterol; Creatine; Glycogen; Heart; Isoproterenol; La | 1966 |